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Summary of Thesis 
Over the years, the surgical management of breast cancer has become less invasive 
due to various factors.  Breast conserving surgery and lesser axillary surgery are performed 
whenever possible.  Early stage at diagnosis made possible by breast screening and earlier 
presentation  of  symptomatic  cancers  due  to  increased  awareness  has  meant  that  more 
patients  are  undergoing  breast  conserving  surgery.    Sentinel  node  biopsy  and  axillary 
sampling have helped reduce arm morbidity.   These changes have made breast cancer 
surgery more amenable to day surgery.  At the same time, the benefits of early discharge 
and day surgery have been increasingly recognised in all surgical specialities.  In 2007, 
when  this  research  was  undertaken,  majority  of  breast  cancer  patients  in  Glasgow 
underwent operations as inpatients.  
The aims of this thesis were to establish the evidence base for day surgery in breast 
cancer and analyse the feasibility, acceptability and safety of performing day surgery in 
breast cancer patients in Glasgow. 
In Chapter 2, a systematic review of literature for studies comparing day surgery 
with inpatient surgery in breast cancer is presented. This was undertaken to establish the 
present evidence.  A randomised controlled trial is the gold standard when comparing one 
intervention  with  another.    However,  this  systematic  review  revealed  lack  of  any 
randomised controlled trials in literature comparing day surgery with inpatient surgery for 
breast cancer.  Only observational studies were found and these showed day surgery for 
breast cancer to be safe with high patient satisfaction. 
In  Chapter  3,  the  feasibility  of  day  surgery  for  breast  cancer  in  Glasgow  was 
examined.  The postoperative length of hospital stay of patients undergoing surgery for 
breast cancer was studied across five centres in Glasgow.  It was noted that 50 percent of 
patients  were  discharged  within  a  day  of  their  operation.    An  analysis  of  socio-
demographic and clinico-pathologic factors influencing postoperative length of stay for all 3 
 
 
breast  cancer  surgical  patients  revealed  that  the  most  important  factor  influencing 
postoperative stay was the axillary procedure performed.  It was seen that symptomatic 
cancer  patients  undergo  more  extensive  surgery  and  are  more  likely  to  stay  longer  in 
hospital.    Patients  undergoing  re-operations  contributed  20  percent  to  the  hospital  bed 
utilisation.    Fifty  percent  of  the  patients  who  were  discharged  within  a  day  of  their 
operation, were potentially thought to be suitable for day surgery. 
In  Chapter  4,  the  acceptability  and  safety  of  day  surgery  for  breast  cancer, 
evaluated in a pilot randomised controlled trial is presented.  In this trial, day surgery was 
compared with inpatient surgery for patients undergoing breast conserving surgery with 
axillary  sampling  or  sentinel  node  biopsy.    Physical  and  psychosocial  outcomes  were 
examined using validated questionnaires.  In a patient satisfaction survey, day surgery was 
found  to  be  highly  acceptable  to  patients.    No  difference  was  found  in  the  physical 
outcomes between the two groups.  Day surgery patients were noted to have a significantly 
better quality of life one week after their operation.  Therefore, this trial found day surgery 
to be a safe option. 
In conclusion, the results of the present thesis show that day surgery for breast 
cancer is a feasible option that was rated by the patients as highly acceptable and had better 
quality of life outcomes.  Moreover, equivalent physical outcomes were noted in both the 
groups. 
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1.0 Introduction 
Until recently, breast cancer patients in Glasgow in common with women in the 
whole  of  the  United  Kingdom  (UK)  have  had  their  surgical  treatments  in  hospital  as 
inpatients.  In Glasgow, women have been treated in a variety of inpatient settings.  In one 
hospital in the city, there is a separate breast ward with its own trained nurses.  In the other 
hospitals, patients are either in a surgical ward with general nursing staff or in dedicated 
areas within surgical wards, with specially trained and committed nurses.  In the recent 
past (up to five years ago) when all women having breast surgery in Glasgow had axillary 
clearance, they would stay in hospital 3, 4 or 5 days post-operatively until their drains had 
settled and could be removed.  Very few were offered the opportunity to go home with 
their  drains  in  situ.    These  few  days  in  hospital  meant  that  women  had  time  with 
experienced ward nurses who provided them with information and support.  They had 
regular physiotherapy and exercises.  Being in hospital meant that they met their surgeon 
and breast care nurse daily and patients and staff got to know each other well.  It also 
meant  patients  had  contact  with  other  women  undergoing  similar  procedures.    Some 
patient groups who met in hospital carried on meeting and providing support to each other 
long after their discharge from hospital, remaining friends for years in some cases.  The 
disadvantage of this period of time in hospital was that women were separated from their 
own sources of support at a crucial time.  They were separated from their families and 
especially for younger women their children at a time when they were vulnerable.  They 
saw themselves as ‗patients‘ in a sick role for those days, resting and not returning to their 
normal lives quickly after surgery.  For older patients they were in danger of becoming 
more dependent and institutionalised, even within a few days, potentially delaying  their 
recovery and return to  functioning.  16 
 
 
1.1 Recent changes in breast surgical practise  
Several significant changes have taken place that have gradually altered both the 
practise of breast surgery in Glasgow as well as in the UK as a whole. 
The first change was the introduction of the NHS Breast Screening Programme (in 
Glasgow from 1990 onwards) with a gradual implementation across the city and the West 
of Scotland.  Secondly, over the past 5 years there has been a change in axillary surgery 
and away from axillary clearance for all patients.  A gradual shift has occurred towards the 
smaller procedures of axillary node sampling, blue-dye assisted node sampling and now 
sentinel node biopsy (SNB) with radioisotope and blue dye. 
Partly  as  a  result  of  earlier  detection  through  screening  and  partly  as  result  of 
increased awareness and earlier presentation of symptomatic patients, the third change had 
been towards more breast conserving surgery (BCS).  Although there are always going to 
be patients who need mastectomy, breast conservation rates have increased.  These three 
factors have been considered separately below. 
1.1.1 The Impact of the breast screening programme 
The NHS Breast Screening Programme was initiated as a result of the ‗Forrest 
Report‘, published in 1986.
1  Regular mammography had proven effectiveness in reducing 
breast cancer mortality in women aged over 50 years.
1  Initially the programme offered 3-
yearly mammography to women between the ages of 50 and 64 years.  In 2000, on the 
basis of the evidence gained through pilot studies, the NHS Cancer Plan was implemented 
increasing the upper limit from 64 to 70 years.
2  In 2007, the Cancer Reform Strategy 
announced  further  expansion of the  NHS Breast  Screening  Programme to  increase  the 
service to nine screening rounds between 47 and 73 years with a guarantee that women 
will have their screening before the age of 50 years.
3   
In 2006, 29% of breast cancers in UK were diagnosed in women over the age of 70, 
52% were diagnosed in women between 50 and 70 years of age and 19% in women less 17 
 
 
than 50.  In the 50 to 70 year age group, 52% of cancers were screen detected.  Breast 
screening has also lead to an increase in the number of non-invasive tumours. 
Screen-detected cancers in general have been found to have better prognosis.  They 
have been noted to have a relatively smaller size, with 78% being 20mm in diameter or 
smaller compared to 48% of the symptomatic cancers.
4  Similarly, 28% of screen detected 
cancers were noted to be Grade-1 compared to 12% of symptomatic cancers and 23% had 
node positive disease compared to 51% of the symptomatic cancers.  
This meant that many screen detected cancers particularly non-palpable cancers 
could be treated by breast conserving surgery rather than mastectomy.  As fewer patients 
overall were now node positive, it seemed unjustifiable to continue to carry out axillary 
clearance on everyone, disadvantaging the majority who were node negative.  Women with 
small screen detected cancers were ideal candidates for axillary sampling or SNB and these 
procedures could easily be carried out without the need for an axillary drain. 
1.1.2 Introduction of node sampling and sentinel node biopsy 
The  main  disadvantage  of  axillary  clearance  is  the  potential  morbidity  such  as 
lymphedema,  pain,  stiffness  and  shoulder  weakness.
5    Although  random  four-node 
sampling was shown to be an accurate way to separate node positive from node negative 
patients  in  the  Edinburgh  studies  in  the  1990‘s,  it  is  also  associated  with  morbidity 
particularly  for  node  positive  patients  who  need  axillary  radiotherapy  or  completion 
axillary clearance.  
The first Edinburgh trial compared axillary sampling with mastectomy and radical 
mastectomy  in  a  randomised  study.
6    A  sample  of  four  nodes  was  removed  from  the 
axillary fat which was in relation to the axillary tail of the breast.  Patients who had a 
positive  axillary  sample  were  given  radical  radiotherapy.    There  was  no  significant 
difference between overall survival and locoregional recurrence between the two groups 
after  10  years.    This  was  followed  by  a  further  randomised  trial  comparing  axillary 18 
 
 
sampling  with  axillary  clearance  in  breast  conserving  surgery.
7    The  locoregional 
recurrence and five-year survival in both groups was similar.  However, sampling patients 
had more arm related morbidity due to axillary radiotherapy.  Blue-dye directed four node 
axillary sampling is now performed in the same centre with false negative rates reported at 
2.4%.
8  
The attraction of SNB is that it is a minimally invasive way to stage the axilla.  The 
term  ‗Sentinel  Lymph  Node‘  was  first  used  by  Cabanas  in  the  management  of  penile 
cancers in 1977.
9  The Sentinel Lymph Node hypothesis states that tumour cells from a 
primary carcinoma migrate through lymphatic channels  to  a single lymph node before 
involving further lymph nodes within that basin.  The intraoperative identification of the 
sentinel lymph node in patients with breast carcinoma was shown to be successful by Krag 
et  al.  using  99m-Technetium-labeled  sulfur,  Giuliano  et  al.  using  blue  dye,  and  by 
Albertini et al. using a combination of 99m-Technetium-labeled sulfur colloid and blue 
dye, with initial identification rates reported of 82%, 66%, and 92%, respectively.
10-12  One 
of the earliest studies of sentinel node biopsy in breast was carried out in Glasgow by 
Professor Cooke in 1997.
13  The ALMANAC trial in UK has since shown that SNB is 
associated with reduced arm morbidity and better quality of life than standard axillary 
treatment  and  reported  high  identification  rates  and  low  false  negative  rates.
14,15    The 
international acceptance of the SNB over routine axillary clearance is based on the fact that 
it is associated with a lower risk of the common morbidities noted with axillary clearance.  
The SNB also allows the pathologist to study the few sentinel lymph nodes removed in 
greater detail for tumour burden compared with the examination of a large number of 
lymph nodes removed by clearance.  The 2009 NICE guidelines states that SNB should be 
the treatment of choice for early operable breast cancer with normal axillary ultrasound 
scanning.
16   19 
 
 
These changes therefore to less invasive axillary surgery meant that not all breast 
cancer patients have needed to stay in hospital for the same length of time as they did when 
they all had axillary clearance with drains. 
1.1.3 Evolution of breast surgery 
Breast conserving surgery was first performed in the late 1970‘s. Until then all 
breast cancer patients had mastectomy.  The trials in America and Milan in the late 1970‘s 
and  1980‘s  established  that  breast  conserving  surgery  with  radiotherapy  is  as  safe  as 
mastectomy both in terms of local recurrence and survival from breast cancer. 
Trials  conducted  in  the  1970-1980  period  compared  mastectomy  with 
segmentectomy with or without radiotherapy.  Veronesi in Milan randomised patients with 
tumours  less  than  2  cm  with  no  palpable  axillary  lymph  nodes  to  Halsted  radical 
mastectomy vs. quadrantectomy with axillary node dissection and radiotherapy.  There was 
no difference in disease-free or overall survival, or locoregional recurrence between breast 
conservation  with  radiotherapy  and  radical  mastectomy.
17    This  was  the  first  study  to 
demonstrate that excision of the tumour followed by radiotherapy gave equivalent results 
to  mastectomy.    The  NSAPB  B-06  trial  was  initiated  in  1976  and  evaluated  breast 
conservation in Stage I/II breast cancer.  Fisher and colleagues randomized 1843 patients 
with cancers less than 4 cm into 3 arms: total mastectomy, segmental mastectomy, and 
segmental mastectomy with radiation.  All patients received axillary node dissection, and 
those with positive nodes received adjuvant chemotherapy.  The results of this study at 5 
and 8 years showed no difference in disease-free survival among the 3 groups.
18,19  This 
was  the  first  trial  to  compare  mastectomy  with  wide  local  excision  with  or  without 
radiotherapy.    An  increase  in  local  recurrence  was  noted  in  the  segmentectomy  group 
without radiation.  This supported the use of radiotherapy to reduce local recurrence.  The 
National  Institute  of  Health  Consensus  Conference  in  1990  recommended  breast 
conserving surgery for patients with Stage I and II breast cancer.
20  The randomised trials 20 
 
 
which formed the basis of this statement have since reported long-term results (10 to 18 
years  follow-up)  and  have  shown  no  significant  difference  in  mortality  due  to  breast 
cancer, although the rate of locoregional recurrence has  been found to be higher  after 
breast conserving surgery.
21,22 
In the last two decades, there has been a progressive increase the proportion of 
women undergoing breast conserving surgery.  In Glasgow, at the start of this study, over 
65 percent of women were undergoing BCS.
23  
 21 
 
 
1.2 Recent changes in general surgical practise 
As well as the changes taking place in breast surgery that have been described, 
there have also been significant changes in the philosophy of perioperative care in general 
surgery.    Increasing  evidence  has  shown  that  preoperative  assessment,  optimisation  of 
patients for surgery and early mobilisation is of great benefit to patients.  The idea of ‗fast 
track surgery‘ and rapid return to tasks of daily living reduces morbidity and mortality after 
all types of surgery.  The Whitehall II study showed that the risk of death after any type of 
surgery  was  two-fold  higher  in  patients  who  had  had  seven  or  more  days  off  work 
compared with less than seven days off work.
24 
The concept of fast-track surgery was introduced in the early 1990s.
25  The idea 
encompasses  preoperative  medications,  perioperative  fluid  management,  metabolic  and 
thermoregulation,  fast  track  anaesthetic  and  surgical  techniques  and  management  of 
postoperative pain and nausea and vomiting.  These techniques have been used both for 
patients undergoing day surgery and for inpatients undergoing more complex surgeries 
such colorectal surgery or cardiac surgery.  In these patients, fast track surgery helps in 
early discharge from hospital.
26 
For  general  anaesthetic  cases  the  pharmacokinetics  of  the  newer  generation  of 
drugs used in anaesthesia (sedatives, anaesthetic agents, analgesics and muscle relaxants) 
enable rapid onset of anaesthesia with a short duration of action and predictable effects 
without accumulation and with minimal side effects.  Rapid and short-acting drugs and the 
increasing use of intravenous anaesthetic techniques facilitate the early recovery process.  
Prophylactic use of non-opioid analgesics and antiemetic drugs reduce postoperative side 
effects and enhance recovery while reducing hospital stay.
27 
Studies have evaluated this approach in colonic surgery in randomised controlled 
trials.
28,29    In  one  study,  the  intervention  groups  received  intravenous  fluid  restriction, 
unrestricted  oral  intake  with  prokinetic  agents,  early  ambulation,  and  fixed  regimen 22 
 
 
epidural  analgesia.
29    They  found  a  significant  decrease  in  the  length  of  stay  in  the 
intervention  group  compared  to  the  control  group  (5  days  vs.  7  days)  without  any 
concomitant  increase  in  complications.    Similar  experiences  have  been  found  in  other 
surgical specialties such as cardiac surgery where early tracheal extubation has been found 
to  be  beneficial  and  in  urology  procedures  where  length  of  hospital  stay  has  been 
significantly reduced after minimally invasive procedures.
30,31  This approach requires a 
cooperating  team  of  motivated  nurses,  anaesthetists,  and  surgeons.    Moreover,  patient 
education  and  information  about  the  procedures  and  the  expected  time  course  are 
important.  An essential part of the concept is that the active role of the patient is to be 
emphasized. 23 
 
 
1.3 Changing role of day surgery in general surgery  
The use of day surgery has been increasing gradually over the past 20 years and 
more rapidly over the past few years.  It was first used in children where it was noted in 
1909 by James Nicoll  a Glasgow paediatric Surgeon that ‗bed  rest  was  impractical  in 
children‘ anyway.  Also, that ‗it was detrimental to children to be separated from their 
mothers and be kept in hospital when they could go home‘.
32  
There was a rapid rise in day surgery in the United States of America (USA) where 
it was mainly seen as a way to better utilise resources.  It was seen as being a possible 
alternative to hospitalisation without harm coming to the patient provided good selection 
criteria were employed.
33 
In  UK,  after  the  work  done  by  James  Nicoll,  it  was  only  in  the  1950s  before 
surgeons questioned the wisdom of enforced bed rest following surgery and considered the 
dangers this exposed the patient to.
34 Surgeons were starting to discuss the possibility of 
treating more patients through the same number of beds (due to reduction in lengths of 
stay) and the potential for day surgery to reduce waiting lists.
34,35  The gradual move to day 
surgery in the UK was largely driven by a few enthusiasts throughout the 1970s and 1980s 
until a report entitled ‗Guidelines for day case surgery‘ was produced in 1985 (revised in 
1992) by the Royal College of Surgeons of England.
36  This report stated that ‗day surgery 
is  now  considered  the  best  option  for  50  percent  of  all  patients  undergoing  elective 
procedures‘  and  was  published  at  a  time  when  the  national  average  was  under  15%.  
British Association of Day Surgery (BADS) was founded in 1989 to promote day surgery 
with an emphasis on safety, quality and excellence. 
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1.4 Definitions of day surgery  
Definitions of day surgery vary widely. In the UK, day surgery is defined as the 
admission of selected patients to hospital for a planned surgical procedure with them being 
allowed to return home the same day.
37  However, when comparing day surgery rates for a 
particular operation, it is important to realise that different definitions are used around the 
world and some countries (e.g., North America) include patients with a stay of less than 
24 hours. 
Internationally agreed terminology, abbreviations and definitions as proposed by 
the International Association for Ambulatory Surgery are shown in Table 1.1.
38  25 
 
 
1.5 Global Day Surgery  
Day surgery is fast becoming common for nearly all elective surgery. In countries 
such as the USA and Canada, it accounts for nearly 90% of all surgery performed, but 
remains  much  less  common  in  many  other  countries.
38    A  survey  conducted  by  the 
International  Association  for  Ambulatory  Surgery  in  2003,  which  used  a  basket  of  35 
procedures, found a global increase in day surgery activity but noted wide variation. (Table 
1.2)  USA and Canada followed closely by the Scandinavian countries had the highest 
rates of day surgery.
39  The survey also showed variation within countries between various 
specialties and between the procedures being performed.  Reasons quoted for this variation 
included  limitations  of  data  completeness,  financial  reimbursement  of  day  cases, 
regulations and incentives in different countries and individual practices of surgeons and 
anaesthetists. 26 
 
 
1.6 Current Practice in the United Kingdom 
The  NHS  Plan  2000  in  England  set  a  target  of  performing  75%  of  elective 
operations as day surgery.  The Audit Commission in England in 2001 set forward a basket 
of 25 procedures for the NHS Trusts which are used as performance indicators.
40 (Table 
1.3)  The Planned Care Improvement Programme in Scotland supports the idea of a basket 
of procedures and supports the NHS Trusts to achieve their target.
41 
1.6.1 The British Association of Day Surgery  
BADS published a Directory of Procedures in 2006 covering 160 procedures across 
nine surgical sub-specialities which set targets for surgical teams.
42  Each operation was 
divided  into  four  possible  treatment  options,  ranging  from  management  in  a  treatment 
room to requiring a 72-hour stay in hospital. (Table 1.4) 
While the basket of procedures is a tool for assessing day surgery performance 
across NHS Trusts, the BADS directory has extended its remit and now promotes quality 
care  in  both  day  case  and  the  short  stay  surgery  setting.    Within  the  list  of  BADS 
procedures  breast  biopsy  is  included  (but  not  defined  as  benign  biopsy  or  wide  local 
excision for cancer) and recently sentinel node biopsy has been added.
42  
The trends across UK over the last decade have shown an increase in day surgery, 
however,  there  has  been  a  great  variability  across  NHS  Trusts  both  in  England  and 
Scotland.
43,44  The Scottish report noted the main barriers
 to increasing the use of day 
surgery to be inappropriate and
 inadequate use of day surgery units, poor management and 
organisation
 of day surgery units, and a preference among some clinicians
 for inpatient 
surgery.
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1.7 Selection criteria for Day Surgery 
Selection of patients for day surgery involves a combination of criteria. 
1.7.1 Age 
Both  medical  and  social  problems  tend  to  increase  with  age,  but  these  are 
considered independently, without any arbitrary upper age limit.
45  There is an association 
between  increasing  age  and  the  development  of  significant  changes  in  intra-operative 
haemodynamics  with  more  intraoperative  cardiovascular  events  (OR  =1.4)  noted  in  a 
study.
46  The  study  found  significantly  lower  postoperative  events  (OR  =  0.4), 
postoperative pain (OR = 0.2) and nausea and vomiting (OR = 0.3).  Elderly patients also 
benefit  from  day  surgery  through  a  significant  reduction  in  postoperative  cognitive 
dysfunction.
47  
 This Scandinavian study suggested that elderly patients were less likely to 
have  cognitive  dysfunction  if  they  were  treated  as  out-patients  for  minor  surgical 
procedures (OR = 2.4). 
1.7.2 Obesity  
Current British guidelines suggest patients with a body mass index (BMI) less than 
or equal to 35 kg m
−2 should be acceptable for day surgery, providing there are no other 
contraindications,  while  those  of  BMI  35–40 kg m
−2  should  be  acceptable  for  most 
procedures.
48  Currently, 91 percent of Canadian anaesthetists would accept patients of 
BMI  35–44 kg m
−2  for  day  surgery  and  half  would  accept  patients  over  45 kg m
−2, 
provided they were otherwise healthy.
49  BMI, however, cannot be looked in isolation and 
association of a high BMI with other lifestyle risk factors like smoking and poor overall 
fitness would increase the risks associated. Hypertension, congestive cardiac failure and 
sleep  apnoea  are  also  all  common  in  morbid  obesity  and  dramatically  reduce  the 
acceptability of these patients for day surgery.
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1.8 Why is Day Surgery increasingly being promoted? 
There has always been the argument in favour of day surgery from the patient 
centred point of view and the acknowledgment that hospitalisation might not be good for a 
person.  Physically, as has been described, early mobilisation is good, and psychologically 
patients may perceive their procedure as less serious and therefore be less anxious about it 
by being a day case. 
In  the  background,  however,  is  the  argument  about  the  use  of  NHS  resources. 
Whereas it is imperative that we should be aware of the cost of patient care and be trying to 
use resources wisely, there is resistance to day surgery from clinicians.  This feeling of 
unease centres around the idea that we are hurrying patients out of hospital instead of 
allowing them time to recover; that we are perhaps putting the cost of treatment above the 
quality of care.  There is a feeling that day surgery is adequate and safe but perhaps not 
optimal for patients.  There is worry that the patient centred argument is an excuse for the 
cost argument.  Would this be particularly the case for patients with breast cancer? 
1.8.1 Evidence from day surgery trials 
What is the evidence therefore from trials of day surgery vs. standard inpatient 
care, in terms of physical and psychological outcomes? 
Most of the studies in literature have been carried in laparoscopic cholecystectomy.  
In  a  meta-analysis  of  randomised  trials,  day-case  laparoscopic  cholecystectomy  was 
reported to be a safe and effective way of treating gall stone disease.
50  While there have 
been many clinical trials comparing laparoscopic cholecystectomy done as inpatient and as 
day case, there are very few randomised trials comparing other surgeries.
51  Most studies 
for general surgical procedures have been feasibility studies.
52,53  Laparoscopic Nissen‘s 
fundoplication,  varicose  veins  surgery  and  laparoscopic  inguinal  hernia  repair  have  all 
been reported to be feasible in the day case setting with low readmission rates.
52-54  There 
are  randomised  controlled  trials  comparing  various  outcomes  for  cataract  surgery 29 
 
 
performed as day surgery or inpatient surgery.
55,56  These have reported no significant 
difference in outcomes. 
1.8.2 Mortality and morbidity of day surgery 
The incidence of death and major morbidity directly associated with day surgery is 
extremely low.  Warner and colleagues followed 38,598 ambulatory surgical procedures 
for 30 days after surgery.  They documented only four deaths, two of which were caused 
by myocardial infarction, and two were the result of automobile accidents.
57 In the same 
study, 31 patients (0.08%) had major morbidity including myocardial infarction, central 
nervous system deficit, pulmonary embolism, and respiratory failure.  In their recent work, 
Jenkins and Baker demonstrated similar low mortality rate, 0.5 per 10 000 anaesthetics.
58  
Unplanned return visits to hospital and re-admissions within 30 days directly related to 
day-surgery procedures range from 0.28% to 1.5%.
59,60  In one study there was a steady 
reduction in unplanned postoperative admissions as experience with appropriate clinical 
pathways increased.
61 
1.8.3 Mortality and Morbidity of breast surgery 
The  mortality  rate  after  breast  surgery  is  very  low.    El-Tamer  and  colleagues 
showed that out of 1660 patients who underwent a mastectomy, four (0.24%) died, but 
none of the 1447 patients who underwent breast conserving surgery with axillary surgery 
died.
62  
Overall,  breast  surgery  carries  a  low  morbidity  rate.
62    Patients  undergoing 
mastectomy are more likely to develop complications compared with breast conserving 
surgery.
62    The  most  common  morbidity  found  in  the  above  study  was  wound 
complications with an overall wound infection rate of 3 percent. Gupta and colleagues, in a 
randomised trial found the overall wound infection rate after breast cancer surgery to be 
about 18 percent with no difference in the infection rates with antibiotic prophylaxis.
63  
Rotstein  and  colleagues  found  that  wound  infection  after  breast  cancer  surgery  varied 30 
 
 
between 3 percent for lumpectomies to19 percent for mastectomies.
64  In addition to the 
type of procedure, factors significantly associated with the development of clean surgical 
wound infection included: presence of surgical drains, prolonged preoperative stay, length 
of surgery and greater mean age.  Early complications (within 30 days of surgery) such as 
seroma formation, wound infection and parasthesias have been reported to be significantly 
more common in patients undergoing axillary lymph node dissection compared to sentinel 
lymph node biopsy.
65 
1.8.4 Patient Satisfaction 
A  number  of  studies  have  reported  high  levels  of  patient  satisfaction  with  day 
surgery.
66-68    Patient  satisfaction  can  be  optimized  by  achieving  or  avoiding  certain 
circumstances,  such  as  good  postoperative  pain  control,
69  short  waiting  time  before 
surgery, courtesy of staff and friendly environment; avoidance of patients feeling that they 
are being discharged too early or rushed; follow-up by telephone on the following day.
70 
1.8.5 Economic Outcomes 
The financial benefits of day surgery over inpatient surgery are well established, 
with hospital costs ranging from 10% to 68% lower for day surgery than for the same 
procedures on an inpatient basis.
71,72 
The economic benefits of day surgery include shorter hospital stay, which enables a 
higher number of patients  to  be treated, thereby  reducing waiting  lists.   This  helps  in 
release  of  inpatient  facilities  for  more  complex  and  emergency  cases.    There  is  also 
reduction in disruption of patients‘ daily routines, with lower levels of absence from work 
or problems providing care for others.
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1.9 Possibilities of day surgery for breast cancer 
Given that most women with breast cancer feel well, and their surgery is not always 
extensive  they  would  potentially  be  a  group  to  whom  day  surgery  could  be  offered.  
Women having BCS with or without localisation and SNB would be an ideal group.  In 
thinking  about  day  surgery  for  breast  cancer,  however,  it  is  difficult  to  separate  the 
technical aspects of the operation itself from the ‗whole package‘ of ward care surrounding 
the surgery, as described above.  If a woman having day surgery for her breast cancer is to 
receive this same standard of care as she would get in the ward she may have to have 
multiple trips to the hospital to meet with various team members and this in itself may give 
added  burden  to  the  woman  and  her  family.    Organising  trips  for  breast  care  nurse 
meetings, physiotherapy etc. may be more difficult than having a few days in a ward.  
Without the ward contact with other patients she may feel isolated.  
These are some of the issues I have tried to address in this thesis. I have searched 
the literature to find out what has been studied with regard to breast cancer surgery in a day 
setting.  I will discuss the various outcomes of day surgery for breast cancer and identify 
the deficiencies in present world literature with regards to this.  Although day surgery is 
being promoted in the NHS,
40 I have tried to work how many of our breast cancer patients 
in Glasgow may actually be suitable for day surgery in real life.  I have described current 
practise and studied the length of stay in hospital for our patients now, in order to find out 
how this would change if we were to start to offer day surgery.  I have analysed this across 
the city of Glasgow, looking at the postoperative length of stay (LOS) of all breast cancer 
patients.    The  patients‘  sociodemographic  characteristics,  comorbidities,  their  mode  of 
presentation, stage of disease, the type of operations they underwent and the influence of 
these factors on the postoperative LOS have been examined.  I then hypothesised that day 
surgery was equivalent to inpatient surgery for patients undergoing breast cancer surgery. 
In order to examine this, a pilot randomised controlled trial comparing day surgery with 32 
 
 
inpatient surgery for breast cancer looking at both physical and psychological outcomes 
was carried out.  From this trial I have tried to define key elements of day surgery care that 
should be audited if we are to assess the quality of day surgery for breast cancer in the 
future. 33 
 
 
 
Table 1.1 Internationally agreed terminology, abbreviations and definitions as 
proposed by the International Association for Ambulatory Surgery
38 
Terminology  Synonyms and definitions 
Day surgery (DS)  Ambulatory surgery (AS), same-day surgery, day only 
Day surgery centre (DSC)  Ambulatory surgery centre (ASC), day-surgery unit (DSU), ambulatory surgery 
unit, day clinic 
A centre or facility designed for the optimum management of an ambulatory 
surgery patient 
Extended recovery  23 hours, overnight stay, single night  
Treatments requiring an overnight stay before discharge 
Short stay  Treatments requiring 24–72 hours in hospital before discharge 
Outpatient  A patient treated at a hospital who is not admitted for a stay of 24 hours or more  
Inpatient  A patient admitted into a hospital, public or private, for a stay of 24 hours or 
more 
Office-based surgery/office 
procedure 
An operation or procedure carried out in a medical practitioner‘s professional 
premises, which provide an appropriately-designed, equipped service room(s) for 
its safe performance 
 
Day surgery procedure, 
ambulatory surgery 
procedure 
An operation or procedure which is not outpatient- or office-based, where the 
patient is discharged on the same working day 
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Table 1.2 Selected results from International Association for Ambulatory Surgery 
survey 2003
39 
 
  Percentage of 
total  surgery 
Percentage of 
basket 
Hernia (%)  Lap. Chol. (%)  Breast 
excision (%) 
Mastectomy 
(%) 
Australia 2003  41  74  23  2  65  9 
Belgium 2004  30  -  20  1  58  3 
Canada 2002  87  84  71  44  93  9 
Denmark 2004  55  79  73  19  45  7 
England 2003  -  63  42  3  -  2 
Finland 2003  37  62  46  10  17  - 
France 2003  -  45  8  0  24  7 
Germany 2003  37  61  6  1  35  9 
Hong Kong 2003  -  43  25  5  58  <1 
Italy 2002  29  41  30  2  64  2 
Netherlands 2002  50  70  38  2  41  <1 
Norway 2003  48  68  63  12  46  12 
Poland 2003  2  -  -  -  -  - 
Portugal 2003  11  19  15  1  29  1 
Scotland 2003  39  66  6  1  43  2 
Spain 2003  28 - 44  54  6 -52  0 -10  -  - 
Sweden 2002  50  67  69  11  41  6 
USA 2003   -  84  84  50  98  57 
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Table 1.3 The Audit Commission of England’s Basket of 25 Procedures
40 
 
S.No.  Procedure 
1.  Orchidopexy 
2.  Circumcision 
3.  Inguinal hernia 
4.  Excision of breast lump 
5.  Anal fissure dilation/excision 
6.  Haemorrhoidectomy 
7.  Laparoscopic cholecystectomy 
8.  Varicose vein stripping/ligation 
9.  Transurethral resection of bladder tumour 
10.  Excision of Dupuytren‘s contracture 
11.  Carpal tunnel decompression 
12.  Excision of ganglion 
13.  Arthroscopy 
14.  Bunion operations 
15.  Removal of metalware 
16.  Extraction of cataract 
17.  Correction of squint 
18.  Myringotomy with or without grommets 
19.  Tonsillectomy 
20.  Submucus resection 
21.  Reduction of nasal fracture 
22.  Correction of bat ears 
23.  Dilation and curettage/hysteroscopy 
24.  Diagnostic laparoscopy 
25.  Termination of pregnancy 36 
 
 
 
 
Table 1.4 Treatment options for each procedure from BADS Directory of Procedures 
Treatment option  Description 
Procedure room  Operation  that  may  be  performed  in  a  suitable  clean  environment 
outside of theatres 
Day surgery  Traditional day surgery, discharged without overnight stay 
23 h stay  Patient admitted and discharged within 24 h 
Under 72 h stay  Patient admitted and discharged within 72 h 
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Aims 
The overall aims of this thesis are:  
i)  to establish the existing evidence base for day surgery in breast cancer  
ii)  to evaluate the feasibility of day surgery for breast cancer in Glasgow  
iii)  to find out whether day surgery is safe, acceptable and advantageous for breast 
cancer patients within a randomised controlled trial and 
iv)  to establish key audit outcomes for day surgery in breast cancer 
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Chapter 2 
2.0 Day surgery for breast cancer: A systematic review of the literature 
2.1 Introduction 
In  the  General  Introduction  we  saw  that  over  the  past  decade  both  breast  and 
axillary surgery have become less invasive prompting earlier discharge after surgery.  
2.1.1 Early Discharge Trials 
Over the past decade a number of randomised trials compared early discharge with 
standard care for breast cancer patients.  All of these showed either equivalent or better 
outcomes for early discharge. 
Bonnema  and  colleagues  published  a  paper  in  1998  looking  at  physical  and 
psychological recovery
73 in early discharge patients.  They reported high satisfaction rates 
in  early  discharge  patients  and  no  difference  in  psychosocial  and  physical  outcomes.  
Similarly,  Bundred  and  colleagues  showed  equivalence  between  early  discharge  and 
standard length  of stay  in  physical  and psychological  outcomes.
74   Women discharged 
early  had  less  wound  pain  and  better  shoulder  mobility.    Purushotham  and  colleagues 
randomised patients into standard versus early discharge without drain insertion.  They 
reported no increase in surgical or psychological recovery.
75 
In  another  randomised  trial,  the  cost  of  early  discharge  was  reported  to  be 
significantly lower than standard discharge.
76 
All these trials were done in the era  where all patients universally had axillary 
clearances and therefore early discharge patients went home with their drains or had no 
drains inserted after clearance. 
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2.2 Aim 
The aim of this chapter is to establish, through a systematic review of literature, the 
benefits and disadvantages of day surgery versus inpatient surgery for breast cancer. 40 
 
 
2.3 Methods 
2.3.1 Sources  
The literature search strategy was formulated with the help of a Glasgow University 
librarian.  The Cochrane Library, MEDLINE (including In-Process & Other Non-Indexed 
Citations),  British  Nursing  Index,  CINAHL,  EMBASE  and  PsycINFO  were  searched 
between  1966  and  September  2008.    The  search  strategy  is  detailed  in  Appendix  2.1.  
Titles of the articles were first screened and abstracts of relevant articles obtained.  Full 
texts of all selected articles were retrieved.  The reference lists of obtained articles were 
hand searched.  If any relevant articles were in languages other than English, they were 
translated.  
2.3.2 Study Selection 
Studies included needed to fulfil the following criteria: 
1.  Patients had a diagnosis of breast cancer and underwent true day surgery.  Breast 
Cancer surgery was defined as surgery for both in situ and invasive breast cancers 
including  surgery  to  the  axilla.    Day  surgery  was  defined  as  an  operation  that 
allowed the patient to go home later the same day. 
2.  The  study  was  either  a  randomised  clinical  trial  or  an  observational  study 
comparing day surgery and inpatient surgery for breast cancer.  An observational 
study was defined as an aetiology or effectiveness study using data from an existing 
database, a cross-sectional study, a case series, a case-control design, a design with 
historical  controls,  or  a  cohort  design  as  per  the  MOOSE  guidelines.
77    We 
excluded  review,  discussion  papers  or  expert  opinion  articles  from  the  final 
analysis, but review articles were checked for additional relevant references. 
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2.3.3 Outcomes 
Data for the following outcomes was extracted: 
1.  Discharge Outcomes:  For patients intended for day surgery we recorded the rate of 
and reasons for conversion to an inpatient.  We also recorded readmission rates 
after discharge from the day surgery unit for immediate or early post operative 
complications.  We also recorded whether patients who needed further surgery to 
the breast or axilla had this as a second day case procedure or as inpatients. 
2.  Physical Outcomes:  Nausea, vomiting, pain, wound infection and wound seroma 
or haematoma rates.  
3.  Psychosocial  Outcomes:    Validated  quality  of  life  assessments  and  patient 
satisfaction questionnaires. 
4.  Economic Outcomes 
2.3.4 Assessment of methodological quality 
The full texts of all the relevant articles were independently reviewed and scored by 
the two authors (VSM and SS).  
The methodological quality of the studies was assessed using a checklist that was 
designed for the assessment of both randomised and non-randomised studies of health care 
interventions.
78 
  It  was  modified  to  include  specific  questions  relating  to  the  outcome 
measures above.  The checklist (Table 2.1) included information about participants in the 
studies.    Specifically,  it  included  information  about  whether  the  whole  breast  cancer 
population  during  the  study  period  was  defined  and  whether  their  characteristics  were 
clearly described.  Pre-assessment criteria for selection of patients for day surgery were 
studied.  The check list also included information about whether outcome information was 
collected prospectively, and whether it was clearly defined.  Also, that the follow up period 
was adequate to assess the physical outcomes and psychosocial outcomes.  Specifically, 42 
 
 
follow up to 30 days to assess wound infection according to the CDC (Centre for Disease 
Control and Prevention) criteria was noted.
79 Information about quality of life and patient 
satisfaction was included.  Re-operation information was extracted where possible.  Breast 
cancer patients may need second operations to their breast (re-excision or mastectomy) if 
margins are not clear.  They may also need further axillary surgery if they have positive 
nodes on a sentinel node biopsy or axillary sampling.  These operations are carried out 
within a few weeks of the first operation.  
From  the  checklists,  studies  were  then  given  an  overall  score.    If  there  was  a 
discrepancy in the scores given by the two reviewers, the papers were discussed and a 
consensus reached. 43 
 
 
2.4 Results  
2.4.1 Description of studies 
A total of 454 references were identified through the electronic searches of Medline 
(293), Embase (112), CINAHL (45), BNI (2), PsycINFO (2) and Cochrane (0).  Titles of 
these studies were assessed and 53 relevant abstracts were obtained.  After reading through 
these 53 abstracts, 20 abstracts met our primary inclusion criteria.  The full texts of these 
studies were retrieved.  A further five studies were identified after searching through their 
reference  lists.    Three  of  the  papers  were  in  languages  other  than  English  and  were 
translated to English.
80-82  Eleven of the 25 studies were excluded without being scored for 
the following reasons: their study population also included benign patients,
83 they were not 
true day surgery,
84,85 mainly discussed lengths of stay of patients,
86,87 discussed trends of 
day surgery, 
88-90 were review articles
91,92 and one paper addressed the effects of a post 
surgery telephone survey
93.  Fourteen studies were initially included in the review and 
scored (Table 2.1). Of these, 3 studies were eventually discarded as they scored poorly 
(less than 6 out of a maximum of 13) when the methodological quality was rated.
80,94,95 
Eleven studies were therefore included in this review.
81,82,96-104 There were no randomised 
controlled trials found comparing day surgery with inpatient surgery for breast cancer. All 
the studies included are observational studies.  
2.4.2 Methodological quality of the studies 
None of the studies measured all the 4 outcomes.  The median score obtained by 
the studies was 6.5 with a range of 2 to 9 (Table 2.1) out of a maximum of 13.  Ten studies 
discussed discharge outcomes and physical outcomes.  Patient satisfaction surveys were 
carried out in seven studies but quality of life was addressed using validated questionnaires 
in only one study.
101  Economic outcome was discussed in four of the eleven studies. 
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2.4.3 Participants 
Characteristics of the eleven included studies are detailed in Table 2.2.  There were 
five comparative studies and six case series.  The duration of the studies ranged from 8 to 
108 months.  The number of patients ranged from 32 to 625.  In seven studies, the total 
number of breast cancer patients operated on during the study period was clearly defined 
(Table 2.1).  The age of patients ranged from 17 to 90 years.  Preassessment criteria used 
for selection of patients for day surgery are mentioned in eight of the studies (Table 2.1).  
The main criteria used are fitness for surgery, distance from hospital, social support after 
surgery and patient choice.  In two of the studies, the tumour size (<3cm)
104 and breast 
conserving surgery (BCS)
97 were used as selection criteria for day surgery.  The number of 
patients  declining  day  surgery  in  favour  of  inpatient  surgery  has  been  noted  in  three 
studies.    Two  of  the  studies  report  2  and  3  (1.1%  and  1.4%)  patients  declining  day 
surgery
81,99, while one study by Marchal et al
100 reported 38 (13.9%) of patients declining 
day surgery in favour of inpatient surgery.  The surgery performed to the breast (BCS or 
Mastectomy) and that to the axilla (SNB, Axillary sampling or Axillary Clearance), both 
varied in the studies (Table 2.2).                                                                                                                                                                                                                
An analysis of all the outcome measures considered is detailed below. 
2.4.4 Discharge Outcomes  
Ten of the papers discussed the rate of conversion from day surgery to overnight 
stay and the reasons for this (Table 2.3).  The rate of discharge from day surgery was very 
high and ranged from 86 to 100%, with 7 of the 10 studies showing a discharge rate greater 
than 95%.  
Acute  readmission  rates  i.e.  readmission  with  immediate  or  early  postoperative 
complications after discharge from day surgery was noted in eight of the studies (Table 
2.4).  Six of the studies stated a 0% readmission rate
81,96,98-100,104 while one study
82 reported 
a 6% readmission rate (25 patients  out of 418) for wound related problems and  one
97 45 
 
 
reported a 7% readmission rate (3 procedures out of 45),  one patient  with nausea and 
vomiting, one with dyspnoea and one with a wound haematoma. 
Three studies discussed re-operation while eight did not.  In one study,
96 24 out of 
the 165 patients (14%) underwent re-excision or mastectomy and it was not stated whether 
these were performed as day cases or as inpatient cases.  In the study by Carcano et al
97, 7 
out  of  25  patients  (28%)  underwent  further  axillary  clearance,  of  whom  6  had  their 
operation in day surgery setting again.  In the third study by Marazzo et al
104, 40 patients 
out of the 100 (40%) had further surgery.  These patients were treated with an axillary 
clearance as second operation, all done as inpatients. 
2.4.5 Physical Outcomes 
The  incidence  of  nausea  and  vomiting  ranged  from  0.8  to  12.2%.
81,82,96-98,100,102  
Most  patients  were  managed  with  antiemetics  and  were  able  to  go  home.    However, 
intractable vomiting contributed to 0.8 to 5.4% of the overnight admissions (Table 2.3).  
Post-operative  pain  control  was  addressed  in  5  studies.
81,82,96,100,102    While  adequate 
analgesic control was achieved in 3 of the studies,
81,96,100 1 to 2% of the patients needed 
overnight admission for pain control in the two French studies.
82,100  In both these studies, 
patients who had undergone axillary clearance were noted to have significantly more pain 
and needed admission. 
Wound infection rates varied from 0 to 16% and other wound related complications 
such as haematoma or seroma formation ranged from 1 to 22%.  Only one study had a 30-
day follow-up to check for any wound related problems.
99 
Three of the studies compared the wound complications in the day surgery and 
inpatient  surgery  groups  (Table  2.5).
82,98,103    Wound  infection  rates  in  the  day  patient 
groups range from 1% to 1.9% and in the inpatient groups they ranged from 2.4% to 6%.  
Dravet et al.
82 compared the rate of postoperative seromas in patients who had undergone 
axillary clearance and found a statistically significant difference between the 2 groups (day 46 
 
 
group: 27% vs. inpatient group: 16%).  The overall wound complication rates (including 
wound infection, haematoma and seroma) were found to be similar in both the groups. 
2.4.6 Psychosocial Outcomes 
Validated quality of life assessment tools were used only by Margolese et al.
101  On 
a Psychological Distress Scale and an Emotional Adjustment Index, outpatients in this 
study had less psychological distress (p=<0.09) and better emotional adjustment (p=<0.05).  
Seven of the studies had patient satisfaction questionnaires.  The questions asked 
and the methods of scoring were very variable.  Four of the papers report high levels of 
satisfaction  amongst  95  to  100%  of  the  patients  who  underwent  day  surgery.
81,97,98,104 
Marchal et al 
100 report an overall mean satisfaction score of 8.97 out of a maximum score 
of 10, where 10 was the highest level of satisfaction.  In two of the studies patients were 
asked whether they would have day surgery again.
100,101 In the study by Marchal et al
100 
199 (91%) of patients answered yes to this question. Margolese et al
101 report that while 22 
of the 55 day patients (40%) would have liked to have spent one night in the hospital rather 
than going home on the same day, 4 of the 35 inpatients (12%) would have liked the 
procedure to be done as a day patient rather than staying in. 
2.4.7 Economic Outcomes 
Four of the studies  evaluated the economic outcomes.
97-99,102   Day surgery  was 
found  to  cost  less  in  all  four  studies  with  savings  ranging  from  40%  to  85%  when 
compared to the same operations being carried out as inpatients.  Goodman et al
99 in 1993 
showed that while the cost of the operations was similar in both outpatient and inpatient 
groups, the further 2 to 3 days of stay in the hospital added an average cost of $3000.  
McManus et al
102 compared 110 outpatients with 110 inpatients who either underwent a 
modified radical mastectomy (n=20) or lumpectomy with axillary dissection (n=90).  The 
savings  in  the  outpatient  group  per  modified  radical  mastectomy  was  $4710  and  per 
lumpectomy  with  axillary  dissection  was  $3827  and  showed  an  overall  total  potential 47 
 
 
savings of $341,430 for 110 patients.  Carcano et al
97 showed an average saving of €854 
for every outpatient procedure.  48 
 
 
2.5 Discussion 
From  the  comparative  studies  and  case  series  in  this  review,  it seems  that  day 
surgery is feasible, safe and maybe beneficial for breast cancer patients.  The numbers in 
individual studies are small and the studies are variable.  There is also a lack of good 
quality of life data in these studies.  
There was no clear consensus about pre-assessment criteria.  Some studies included 
medical  fitness for surgery  while others  also  considered social  support for the patient.  
Four  of  the  six  papers  from  Europe  and  UK  only  included  breast  conserving  surgery 
patients in their studies, while four of the five studies from North America have included 
mastectomy patients as well.  Day surgery for breast cancer has been practiced in North 
America since the early 1990s while most studies from the Europe are from the current 
decade.  This is reflected in the papers selected for the present review. 
The rate of discharge from the day surgery unit was high in most of the studies.  
Only three of the studies had overnight admission rates which were greater than 10%.  
Nausea and vomiting was cited as one of the main reasons for this.  Potentially with good 
antiemetics and adhering to guidelines suggested for ambulatory anaesthesia, this could be 
controlled.
105  Patient anxiety could be addressed with better preoperative education of the 
patients. One paper sites over-running theatre lists as a cause for overnight admissions.
96  
No study has cited lack of social support as a reason for failed discharge.  Readmissions 
for acute postoperative complications have been very low and none of the complications 
have been life threatening.  
We recognise that some patients undergo a second procedure for their breast cancer 
which may or may not be performed in Day Surgery.  Re-operation surgery may therefore 
add to the workload of a Day Surgery service.  Some patients having re-operation may 
need an inpatient stay, as mastectomy and axillary clearance are currently not carried out in 
the UK in a Day Surgery setting.  49 
 
 
Nausea,  vomiting  and  pain  issues  in  general  appear  to  be  well  controlled  with 
medications and in majority of the trials patients were discharged from day surgery.  Some 
of the early discharge studies had attempted to assess the impact of early discharge on 
General  Practitioners  in  the  community.    None  of  the  studies  in  the  present  review 
recorded whether patients discharged from day surgery went to their General Practitioners 
for further advice or for treatment of any postoperative complications and hence we could 
not assess this.  This would have highlighted whether there was any extra burden on the 
community after discharge of the patient.  Further studies should address this as part of 
evaluation of day surgery.  Wound infection rates are variable and appear to be poorly 
recorded.  Only one study had a 30-day follow-up wound surveillance.
99 
Psychosocial outcomes have been very poorly addressed in the studies.  Quality of 
life assessment using validated questionnaires was addressed in only one study
101 and this 
showed better psychological and emotional adjustment in the day surgery group.  In future, 
use of validated questionnaires to address quality of life issues in a randomised setting 
should be considered.  Patient satisfaction with day surgery in all the studies has been high.  
None of the papers report dissatisfaction with day surgery.   In one study
101 where the 
patients were asked whether they would have their operation in the same setting as before, 
22 of the 55 day patients said they would have wanted one night in hospital and four of the 
35 inpatients would have wanted day surgery instead.  All the patients in this study were 
interviewed by phone about 16 to 30 months after their operation retrospectively.  Only 90 
of the 121 patients (74%) agreed to be interviewed and the researchers depended on the 
patients‘ memory of the events and how they felt about them.  Clearly this shows that 
patient satisfaction surveys performed have not been a robust measure of the outcome.  
Several papers
82,98,100,102 in the present review have also stressed the importance of pre-
operative  education of  patients  and their  carers coming  for day surgery, using various 
different approaches including written material and educational sessions.  This has been 50 
 
 
commented  to  increase  the  understanding  and  involvement  of  the  patients  and  their 
relatives and hence play a key role in their successful management. 
Economic outcomes have mainly been evaluated in the American papers.  Clearly 
the  clinical  outcomes  are  paramount,  but  given  clinical  equivalence,  cost  is  also  an 
important factor for the NHS. 
None  of  the  papers  reviewed  discussed  the  issue  of  post-operative  drain 
management.    It  is  an  important  issue  and  has  been  discussed  in  papers  about  early 
discharge after breast surgery.
74,75  In one of the studies in our review
96 the patients had 
axillary clearance carried out in Day Surgery but without drains being inserted.   Most 
patients in present practice have either a sentinel node biopsy or axillary node sampling 
and may not need a drain.  However, optimum early follow-up of patients with drains is 
not clear and may need further study.  
The care of a breast cancer patient involves more than just a surgical procedure.  
They require emotional support, counselling and information about their disease and its 
management.  Currently, as inpatients, women receive support from their surgeon, breast 
care nurse, ward nurses and interaction with other breast cancer patients in hospital.  In the 
future when more patients have their surgery in a day surgery setting, we need to find new 
ways to provide this support and information which they would have had in hospital.  51 
 
 
2.6 Conclusions 
Day  surgery  for  breast  cancer  appears  to  be  safe  and  well  tolerated  with  good 
satisfaction rates.  Further research is needed to address both physical and psychological 
outcomes in randomised controlled trials using appropriate validated questionnaires.   
 
 
Table 2.1 Checklist to assess the methodological quality of the studies 
 
 
 
 
 
 
 
 
 
Dooley 
et al
98 
Margolese 
et al
101 
Seltzer 
et al
103 
McManus 
et al
102 
Marrazzo 
et al
104 
Athey 
et al
96 
Carcano 
et al
97 
Marchal 
et al
100 
Friedman 
et al
81 
Dravet 
et al
82 
Goodman 
et al
99 
Tan 
et al
94 
Barillari 
et al
80 
Dalton 
et al
95 
Is there information about all the breast cancers operated 
on in the study period from which day surgery patients 
were selected? 
No  Yes  No  No  Yes  Yes  No  Yes  Yes  Yes  Yes  Yes  No  No 
Are  the  characteristics  of  the  patients  included  in  the 
study clearly described? 
Yes  Yes  Yes  Yes  Yes  Yes  Yes  Yes  Yes  Yes  Yes  Yes  No  No 
Is it a Comparative Study?  Yes  Yes  Yes  Yes  No  No  No  No  No  Yes  No  No  No  No 
Were there proper pre-assessment criteria?  No  No  Yes  No  Yes  Yes  Yes  Yes  Yes  Yes  Yes  No  No  No 
Is the follow-up period adequate?  No  No  No  No  No  Yes  No  No  No  No  No  Yes  No  No 
Are the main outcomes to be measured clearly described 
in the Introduction or Methods section? 
No  Yes  No  No  No  Yes  Yes  Yes  No  Yes  No  No  No  No 
Were the outcomes assessed prospectively?  Yes  No  Yes  No  No  Yes  Yes  Yes  No  Yes  Yes  No  No  No 
Are lengths of stay related issues (discharge rate/reason 
for overnight stay/readmissions) addressed? 
Yes  No  Yes  Yes  Yes  Yes  Yes  Yes  Yes  Yes  Yes  No  Yes  Yes 
Were  Physical  Outcomes  noted  (N/V/Pain/Wound 
issues)? 
Yes  No  Yes  Yes  Yes  Yes  Yes  Yes  Yes  Yes  Yes  No  No  No 
Was  Quality  of  Life  addressed  using  validated 
questionnaires? 
No  Yes  No  No  No  No  No  No  No  No  No  No  No  No 
Were there any patient satisfaction surveys?  Yes  Yes  No  Yes  Yes  No  Yes  Yes  Yes  No  No  No  Yes  No 
Was economic cost evaluated?  Yes  No  No  Yes  No  No  Yes  No  No  No  Yes  No  No  Yes 
Were further reoperations for breast cancer noted?  No  No  No  No  Yes  Yes  Yes  No  No  No  No  No  No  No 
 Overall Score (13)  7  6  6  6  7  9  9  8  6  8  7  3  2  2  
 
 
 
 
 
Table 2.2 Characteristics of studies included in the systematic review 
S. No.  Study  Year  Study design  Patient group  Age (years)* 
Duration of study  
(months) 
Type of 
surgery**  Location 
1  Dravet et al
82  2000  Comparative  625 
DP=418, IP=207 
Mean age 
IP = 58 (29-91) 
DP = 51(20-80) 
12  c + f  France 
2  Margolese et al 
101  2000  Comparative  90 
DP=55, IP=35 
Mean age 
IP=58, DP=57 
27  c +  e  Canada 
3  Seltzer et al
103  1995  Comparative  178 
DP=135, IP=45 
Mean age 
IP=56, DP=55 
108  a + e  US 
4  McManus et al
102  1994  Comparative  173 
DP=118, IP=55 
NR  30  c + e  US 
5  Dooley et al
98  2002  Comparative  87 
DP=87, IP=not 
known 
Mean age= 59 
(38 to 84) 
8  c +  f  US 
6  Marchal et al
100  2005  Case series  236  Mean age = 50 
(17-76) 
12  a + e  France 
7  Athey et al
96  2005  Case series  165  Median age = 55 (39-
76) 
26  a + f  UK 
8  Carcano et al
97  2005  Case series  32  Mean age = 57 
(34-73) 
15  a + f  Italy 
9  Marrazzo et al
104  2007  Case series  100  Mean age = 56 
(30-82) 
16  a + d  Italy 
10  Friedman et al
81  2004  Case series  181  Mean age = 60 
(28-92) 
33  c + f  Italy 
11  Goodman et al
99  1993  Case series  223  34-90  22  c + e  US 
 
*IP: Inpatient, DP: Day patient 
**Type of surgeries performed: Breast: a: Breast Conserving Surgery, b: Mastectomy, c: Both Breast Conserving Surgery and Mastectomy and 
 Axilla: d: Sentinel Node Biopsy, e: Axillary Clearance, f: Both Sentinel Node Biopsy and Axillary Clearance.  
 
 
 
 
Table 2.3 Rate of discharge from Day Surgery (DS) and reasons for overnight stay 
 
Study 
No. of procedures 
in DS 
Rate of discharge 
from DS - no. (%) 
Nausea/ Vomiting 
- no. (%) 
Anxiety/ 
Patient Choice - 
no. (%) 
Pain Issues - 
no. (%) 
Wound 
Complications - 
no. (%) 
Medical 
Complications - no. 
(%) 
Overrunning 
theatre lists- 
no. (%) 
Seltzer et al
103  133  133 (100)  -  -  -  -  -  - 
Carcano et al
97  32  32 (100)  -  -  -  -  -  - 
Goodman et al
99  223  223 (100)  -  -  -  -  -  - 
Dooley et al
98  92  91 (99)  -  1 (1.0)  -  -  -  - 
Friedman et al
81  181  179 (99)  -  2  (1.0)  -  -  -  - 
McManus et al
102  118  115 (98)  1 (0.9)  -  -  1 (0.9)   1 (0.9)  - 
Marrazzo et al
104  100  96 (96)  -  4 (4.0)  -  -  -  - 
Athey et al
96  165  149 (90)  2 (0.1)  -  -  1 (0.1)  2 (0.1)  11 (6.7) 
Dravet et al
82  418  366 (88)  19 (4.5)  11 (2.6)  5 (1.2)  11 (2.6)  3 (0.7)  3 (0.7) 
Marchal et al
100  274  236 (86)  16 (5.8)  14 (5.1)  6 (2.2)  2 (0.7)  -  - 
Margolese et al 
101  55  -  -  -  -  -  -  - 
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Table 2.4 Acute readmission rates following discharge from day surgery unit 
Study 
Acute 
readmissions 
Dooley et al
98  0 
Goodman et al
99  0 
Friedman et al
81  0 
Marchal et al
100  0 
Athey et al
96  0 
Marrazzo et al
104  0 
Dravet et al
82  25 (7%) 
Carcano et al
97  3 (8%) 
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Table 2.5 Comparison of wound infection and overall wound complication rates 
between the day surgery and inpatient surgery groups 
 
  Wound Infection Rates 
Overall Wound Complication 
Rates 
 
Day Surgery 
Group 
Inpatient 
Group 
Day Surgery 
Group 
Inpatient 
Group 
Dooley et al
98 
(day surgery group = 92, 
inpatient  group  number  not 
known) 
1%  6%  -  - 
Dravet  et  al
82  (day  surgery 
group = 418, 
inpatient group = 207) 
1.9%  2.4%  6.0%  7.7% 
Seltzer et al
103 
(day surgery group = 133, 
inpatient group = 45) 
1.5%  4.4%  5.4%  6.6% 
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Figure  2.1  Flow  chart  of  articles  identified,  included  and  excluded  in  the 
systematic review 
References  identified  through 
combined  search  of  6  databases  and 
hand searches n = 459 
Considered not relevant based on title  
n = 401  
Publications selected on title n = 58 
Full texts selected n = 25 
Full texts included in quality assessment 
scoring n = 14 
Full  texts  eligible  for  systematic 
review n = 11 
Considered not relevant based on abstract 
n = 33 
 
Scored poorly on methodological assessment  
n = 3 
Excluded n = 11 
1  Included benign patients n = 1 
2  Not true day surgery n = 2 
3  Discussed lengths of postoperative stay only n = 2 
4  Review articles without any data n = 2   
5  Discussed trends of day surgery n = 3   
6  Discussed effects of telephonic survey n = 1  
     58 
 
 
 
Chapter 3 
3.0 Postoperative length of hospital stay after breast cancer surgery and factors 
influencing this: Current practise in Glasgow (2007-08) 
3.1 Introduction 
From the findings of the previous chapter, it appears that day surgery is a safe 
and feasible option for breast cancer patients.  The postoperative length of stay (LOS) 
after breast cancer surgery and the factors that influence it in the current practise in 
Glasgow is analysed in this chapter. 
3.1.1 Breast cancer population in Glasgow 
Patients  with  breast  cancer  either  present  via  their  General  Practitioner  to  a 
symptomatic breast clinic in one of the five hospitals or present through the breast 
screening programme.  Over the period of the study, two new Day Hospitals have been 
built in Glasgow but none of the patients in this study were treated in either.  In the 
West of Scotland, the target screening population is 2,45,000 women which is half the 
screening population of Scotland.  Patients with screen detected cancers are operated on 
in  two  designated  hospitals  if  they  have  non-palpable  cancers  and  in  any  hospital 
(designated or local) if they have palpable cancers.  All the women studied had primary 
operable breast cancers. Women treated non-surgically over the study period have not 
been included.  
3.1.2 Length of stay for breast cancer population 
With the increasing incidence of breast cancer,
106 the number of admissions to 
breast units for breast cancer surgery has risen.  At the same time, the average LOS for 
patients with breast cancer has been falling in the UK and other European countries 
over the past two decades, thus helping in accommodating the increase in number of 59 
 
 
admissions.
107  In the UK, the average LOS has fallen from 9.8 days in 1990 to 5.2 days 
in 2005.
107  
3.1.3 Factors influencing length of stay 
Various factors influencing postoperative LOS have been studied for surgical 
admissions.    LOS  may  be  affected  by  patient  factors  such  as  older  age,  gender, 
comorbidities  and  sociodemographics,
108,109  and  intraoperative  and  postoperative 
adverse events and complications.
109,110  A combination of patient factors and quality of 
perioperative care have been noted to affect  LOS.
109 Specifically, in breast surgery 
there are few LOS studies and those that exist have studied trends over several decades 
in  LOS  for  breast  cancer  surgery.
111-113    The  trend  towards  increasing  number  of 
patients undergoing BCS than mastectomy has been universally noted as one of the 
major factors for the decrease in LOS over the last two decades.  The adoption of newer 
techniques such as axillary sampling and SNB and move towards early discharge have 
also been shown to be important factors in decreasing LOS.
112  None of the studies 
have specifically tried to explain the variation in LOS among women having BCS or 
having mastectomy. 60 
 
 
3.2 Aims 
The  aims  of  the  present  study  were  (i)  to  record  the  LOS  for  patients 
undergoing  breast  cancer  surgery,  (ii)  to  compare  the  socio-demographic,  clinico-
pathologic factors and the LOS in screen detected and symptomatic  cancers, (iii) the 
factors influencing prolonged postoperative LOS in screen detected and symptomatic 
breast cancers and (iv) the impact of each breast procedure on hospital bed utilisation. 61 
 
 
3.3 Methods 
The study analysed admissions for surgical procedures carried out for breast 
cancer at five breast units in Glasgow (Centres A, B, C, D and E).  The data of all 
patients admitted at Victoria Infirmary (Centre A) with a diagnosis of invasive breast 
cancer or ductal carcinoma in situ (DCIS) undergoing breast surgery over a 12 month 
period (March 2007 to February 2008) was prospectively collected by a daily record of 
all admissions and discharges by the researcher on a data base.  Data for all surgical 
admissions and discharges in women with new diagnosis of breast cancer  over a six-
month  period  (March  to  August  2007)  for  four  breast  units  at  Western  Infirmary 
(Centre B), Glasgow Royal  Infirmary (Centre C), Stobhill Hospital (Centre D) and 
Canniesburn Plastic and Reconstructive Surgery Unit (Centre E) was obtained from the 
PASWEB (Patient Administration System). PASWEB is the software which holds all 
the admission and discharge data for the patients. The admissions and discharges for all 
patients are noted each night from all the wards in the hospitals and entered on the 
PASWEB system. This data is cross checked by clinical effectiveness department. It 
was used to obtain admission and discharge dates for each patient. LOS was calculated 
from this information obtained by the researcher. As the researcher was working at one 
hospital for the whole period of the study, it was feasible for him to prospectively 
collect data for the whole 12 months, while information for the other hospitals was 
obtained from hospital databases and it had been feasible to get only 6 months of data.  
All pathology reports were reviewed to confirm diagnosis through the clinical portal 
using patient unit numbers. Information about patient comorbidities was obtained from 
Scottish  Medical  Record‘s  SMR  01  data  form  from  ISD  (Information  Services 
Division) Scotland. 
Information recorded on the database included age, socio-demographic factors 
(deprivation  category  and  distance  between  patient‘s  residence  and  the  hospital  of 62 
 
 
operation), patient comorbidity measured using Charlson Comorbidity Index,
114 mode 
of detection (screen detected or symptomatic), hospital where the operation took place, 
diagnosis  (DCIS  or  invasive  breast  cancer),  operative  procedure  performed  on  the 
breast and axilla, the tumour size, stage of disease (in situ, early breast cancer and 
locally advanced or distant disease), and postoperative LOS.  Preoperative LOS was 
recorded but not included in the analysis because almost all patients were admitted the 
day before surgery and standard methods of measuring hospital LOS are from the time 
of the index procedure. 
Definition  of  operative  procedures:  Operative  procedures  on  breast  included 
BCS,  mastectomy  and  mastectomy  with  some  reconstructive  procedure.  
Simultaneously, patients could also have undergone axillary surgery.  Surgeries in the 
axilla included axillary sampling, SNB or axillary clearance.  Re-operations included 
re-excision  of  the  breast  lesion  and  mastectomy,  with  or  without  further  axillary 
surgery. 
Deprivation  category  (Depcat)  was  defined  using  the  Carstair‘s  Deprivation 
Index.
115 
Definition of prolonged postoperative LOS: Postoperative LOS was defined as 
the time from the date of the index operation to the date of discharge, transfer to a 
subacute service or death, whichever came first.  A prolonged LOS was defined as a 
LOS greater than or equal to the 75
th percentile for each index operation, including the 
date of discharge.  This definition was in keeping with previous studies.
109,110  
The factors influencing postoperative LOS for all patients were identified after 
dividing  the  patients  according  to  mode  of  detection  into  screen  detected  and 
symptomatic cancers.  Independent predictors of postoperative LOS were identified for 
each group by logistic regression analysis.   
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3.3.1 Statistical Analysis 
Significance  of  the  continuous  variable,  LOS  in  screen  detected  and 
symptomatic  groups  was  calculated  using  Mann-Whitney  U  test.    All  categorical 
variables comparing screen detected and symptomatic cancers and factors influencing 
LOS were compared using Χ
2 test or Fisher‘s test as appropriate.  A p-value of <0.050 
was considered statistically significant.  Independent affects of variables found to be 
significant or nearly significant on univariate analysis for predicting prolonged LOS 
were  assessed  using  binary  logistic  regression  analysis  and  presented  as  odds  ratio 
(OR) with confidence interval (C.I.) and p-value.  All statistical analysis was performed 
using  the  statistical  package  SPSS
®  for  Windows
®  Version  15.0  (SPSS,  Chicago, 
Illinois, USA).  64 
 
 
3.4 Results  
Over the study period, 519 women underwent surgery for breast cancer at the 
five  centres.    There  were  252  (49  percent)  screen  detected  and  267  (51  percent) 
symptomatic cancer patients.  The socio-demographic and clinical characteristics of 
screen detected and symptomatic breast cancer patients are shown in Table 3.1.  There 
was  no  significant  difference  in  the  age  or  deprivation  category  distribution  in  the 
screen detected and symptomatic cancers.  There was a significant difference in the 
distribution of screen detected and symptomatic cancers across the five centres as all 
the non-palpable cancers were operated only at Centre A or B (p<0.001).  The screen 
detected and symptomatic cancers significantly differed in the Charlson Comorbidity 
Index scores (p=0.007), stage of disease (p<0.001) and tumour size (p<0.001).  
3.4.1 Length of stay after breast surgery 
Including all types of surgery, the overall median length of stay for patients was 
one day (range 0-24) and 50 percent of all patients were discharged within one day of 
surgery.  The median postoperative LOS for screen-detected cancers was one day and 
for symptomatic cancers it was 4 days (p<0.001).  There was a significant difference in 
the number of screen detected and symptomatic patients being discharged within one 
day of their surgery (p<0.001).   While 75 percent of screen detected patients were 
discharged within a day of their operation, 26 percent of symptomatic patients were 
discharged within a day of their operation.  
The  median  LOS  for  patients  undergoing  BCS  was  one  day  and  the  75
th 
percentile LOS was also one day.  The median LOS for mastectomy patients was five 
days,  while  the  75
th  percentile  LOS  was  six  days.    The  median  LOS  for  patients 
undergoing mastectomy with reconstruction was seven days, and the 75
th percentile 
LOS was 8 days for this group. 65 
 
 
The relationship between the socio-demographic and clinico-pathologic factors 
and postoperative LOS in screen detected cancers is shown in Table 3.2.  Factors found 
to  be  significantly  associated  with  prolonged  LOS  on  univariate  analysis  were  the 
axillary  procedure  (p<0.001),  the  tumour  size  (p=0.007)  and  the  cancer  stage 
(p=0.016).  Multivariate analysis of these factors (Table 3.4) shows that the axillary 
procedure performed (odds ratio = 5.61, p<0.001) and the tumour size (odds ratio = 
1.61, p=0.059) independently influenced prolonged postoperative LOS. 
The relationship between the socio-demographic and clinico-pathologic factors 
and postoperative LOS in symptomatic cancers is shown in Table 3.3.  Factors found to 
be  significantly  associated  with  prolonged  LOS  on  univariate  analysis  were  the 
deprivation  category  (p=0.008),  the  breast  procedure  (p=0.026)  and  the  axillary 
procedure (p<0.010).  Multivariate analysis of all factors nearing significance (p<0.1) 
shows (Table 3.4) that the axillary procedure performed (odds ratio = 2.06, p=0.002), 
the  Charlson  Comorbidity  Score  (odds  ratio  =  1.74,  p=0.049)  and  the  deprivation 
category  (odds  ratio  =  1.48,  p=0.045)  independently  influenced  prolonged 
postoperative LOS. 
3.4.2 Hospital bed utilisation 
  A more detailed study of all the procedures performed at Centre A shows that 
185 patients (63 percent) underwent breast conserving surgery with or without axillary 
surgery (BCS ± SNB/Axillary Sampling/Axillary Clearance) and had a median length 
of stay of one day (Table 3.5).  They utilised 256 hospital bed days (29 percent). Sixty 
six  patients  (23  percent)  underwent  mastectomy  with  or  without  axillary  surgery 
(Mastectomy ± SNB/Axillary Sampling/Axillary Clearance) and utilised 451 hospital 
bed days (51 percent).  Forty two re-operations (14 percent) were performed with the 
patients having a median length of stay of 4 days.  These patients utilised a further 175 
hospital bed days (20 percent).  The most common re-operation procedures performed 66 
 
 
(19 patients) were axillary clearance with or without further surgery to the breast (RE 
or mastectomy). Of the 175 hospital bed days, these patients utilised 121 hospital bed 
days.  Nineteen patients underwent re-excision with or without axillary sampling and 
utilised 37 hospital bed days, 2 patients underwent mastectomy alone and added 13 
days while 2 patients had wound problems and added 4 days. 67 
 
 
3.5 Discussion 
This study of postoperative LOS after breast cancer surgery in Glasgow shows 
that in 2007-08, 50 percent of the patients were discharged from hospital within a day 
of their operation. (Table 3.1)  This suggests that, potentially 50 percent of the patients 
undergoing  breast  cancer  surgery  in  the  present  setting  could  be  considered  for 
treatment in a day surgery or 23-hour care facility.  However, not all the 50 percent 
would have passed the day surgery pre-assessment criteria.  Although in practise they 
were discharged after one day, they may not have been suitable for day surgery.  Some 
of these patients, for example, may have had comorbidities which would mean their 
surgical team were happier to treat them as inpatients, even though in the event they 
were fine, they would go home the next day after surgery.  Similarly, some fit and 
healthy women currently staying in for four days with a drain would be potentially 
suitable for day surgery or 23-hour care, going home with or without a drain. 
The  postoperative  LOS  was  significantly  different  in  screen  detected  and 
symptomatic cancer patients. (Table 3.1)  It is well established that breast screening 
helps  detect  cancers  at  an  earlier  stage
4,116,117  and  screen  detected  cancers  more 
frequently  undergo  BCS  procedures.
118  In  the  present  study,  the  difference  in 
postoperative  LOS  can  be  attributed  to  the  difference  in  the  stage  of  disease  at 
presentation.  Larger tumour size and more advanced disease meant that patients in the 
symptomatic  group  had  more  extensive  surgery  and  stayed  longer  in  hospital 
postoperatively.  A higher proportion of patients in the symptomatic group were noted 
to be from the more deprived areas compared to the screen detected cancer group (38% 
vs 24%), although this was not statistically significant. This is in keeping with the 
national trends.
4  In Glasgow, the screen detected cancers are referred to Centre A and 
B  and  hence  the  distribution  of  screen  detected  and  symptomatic  cancers  shows 
variation across the centres.  68 
 
 
The  overall  level  of  comorbidity  amongst  women  undergoing  operative 
treatment  for  breast  cancer  was  very  low  (11  percent).    There  was  a  significant 
difference  in  the  incidence  of  comorbidities  between  the  screen  detected  and 
symptomatic cancer groups, suggesting that the cohort of screen detected cancers is 
different from the symptomatic cancers.  The screen detected cancer patients are more 
likely to be healthier and have earlier stage disease.  But, the fact that few patients had 
significant comorbidities is encouraging and would support the possibility that majority 
of patients would be suitable for day surgery.  Data on comorbidity was obtained from 
SMR01 data which is collected uniformly on every hospital admission in Scotland.  
Morbidities are ranked with breast cancer as the first comorbidity with up to the first 
six comorbidities being recorded.  It is very accurate information which is regularly 
audited.    If  this  study  was  to  be  repeated,  in  addition  to  the  SMR01  information, 
perhaps more detailed information about the patients‘ functioning at home should be 
collected. 
In view of this difference between the screen detected and symptomatic cancers, 
the  factors  influencing  the  postoperative  LOS  in  these  two  groups  were  studied 
separately. 
In the screen detected cancers, the sociodemographic factors (age, deprivation 
and  distance  from  hospital)  and  patient  comorbidities  did  not  have  a  statistically 
significant affect on prolonged LOS.  Tumour characteristics which were statistically 
associated with prolonged LOS were the axillary procedure and the size of tumour.  
While the size of tumour was noted to have some affect on prolonged LOS (odds ratio 
= 1.61, p=0.059), the axillary procedure had the maximum affect (odds ratio = 5.61, 
p<0.001) and appears to be the most important factor in determining LOS in the screen 
detected cancer patients.  Majority of the patients in this group had breast conserving 
surgery (213 of the 252 patients) and it is known that screen detected cancers are less 69 
 
 
likely to have axillary nodal involvement and hence tend to have less extensive axillary 
procedures.  However, if these patients undergo axillary clearance, it affects their LOS 
significantly. 
In  the  symptomatic  cancers,  the  axillary  procedure  (odds  ration  =  2.06, 
p=0.002), comorbidity (odds ratio = 1.74, p=0.049) and the deprivation category (odds 
ratio = 1.48, p=0.045) were found to have a statistically significant affect on prolonged 
LOS.  Although the effect of the axillary procedure was not as significant as the screen 
detected group, it was still the most important determinant.  More patients in this group 
had associated comorbidities and this had some affect on the LOS.  Thirty nine percent 
of  patients  in  the  most  deprived  categories  had  a  prolonged  LOS  compared  to  23 
percent  and  19  percent  in  the  other  categories.    Therefore,  we  note  that  while 
comorbidities and deprivation category do not influence LOS in the screen detected 
cancers, they have some influence on the LOS in the symptomatic cancers. 
When we analysed the patient population at Centre A to ascertain the overall 
effect  of  each  procedure  on  the  cumulative  hospital  bed  occupancy,  mastectomies 
contributed  more  than  50  percent  to  this  while  breast  conserving  surgery  patients 
contributed 29 percent.  Forty two patients (14 percent) underwent reoperations and 
contributed a further 20 percent to the bed occupancy.  The majority of patients in this 
group  were  patients  who  had  previously  undergone  breast  conserving  surgery  and 
needed further surgery to the breast (re-excision or mastectomy) and/or to the axilla 
(axillary clearance).  Majority of patients in this group stayed in hospital for ≥2 days 
and  they  may  not  be  suitable  for  reoperation  in  a  day  surgery  setting.    Axillary 
clearance seemed to be the most important factor contributing 121 of the 175 days that 
the re-operations added. 
Overall,  the  axillary  procedure  performed  appears  to  be  the  most  important 
determinant of prolonged LOS.  All the patients who underwent an axillary clearance 70 
 
 
had an axillary drain inserted which is the most important contributor to these patients‘ 
prolonged LOS.  Many studies have attempted to reduce the LOS by either sending 
patients home with a drain in situ,
119,120 or by not inserting a drain at all,
75,96,121 with 
safe outcomes.  Sending patients home with the drain in situ is a feasible option for our 
patients but would require patient education and support from the community nurse. 
This needs to be assessed further.  
 71 
 
 
3.6 Conclusions 
In conclusion, we note that in our current practise in Glasgow, 50 percent of the 
women having operations for breast cancer as inpatients were discharged within one 
day postoperatively.  Most of these would have been suitable for day surgery and the 
rest potentially for 23-hour care within a day surgery hospital.  Some of these patients 
will still need a second inpatient admission for reoperation.  These readmissions as 
inpatients need to feature in planning a day surgery service. 
Axillary  procedure  appears  to  be  the  main  determinant  of  prolonged  LOS. 
Sending  patients  home  with  a  drain  in  situ  may  be  an  option  which  needs  to  be 
considered in these women.  
While  patients  undergoing  mastectomies  with  or  without  axillary  surgery 
contribute to  half of the bed occupancy,  a further 20 percent  is  contributed by re-
operations.  
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Table 3.1 Socio-demographic and clinical characteristics of screen detected and 
symptomatic breast cancer patients 
 
 
Screen Detected 
Cancers (%) 
Symptomatic 
Cancers (%)  Total (%)  p value 
Number of patients  252 (49)  267 (51)  519   
Factors  Categories         
Age (years)  <50  0 (0)  68 (26)  68 (13) 
0.253 
50 - 69  216 (86)  109 (41)  325 (63) 
>70  36 (14)  90 (34)  124 (27) 
Deprivation 
category 
 
Group 1 (Depcat 1/2)  43 (17)  57 (21)  100 (19) 
0.101 
Group 2 (Depcat 3/4/5)  149 (59)  108 (40)  257 (50) 
Group 3 (Depcat 6/7)  60 (24)  102 (38)  162 (31) 
Centre  A  168 (67)  83 (31)  251 (48) 
<0.001 
B  69 (27)  54 (20)  123 (24) 
C  0 (0)  50 (19)  50 (10) 
D  0 (0)  46 (17)  46 (9) 
E  15 (6)  34 (13)  49 (9) 
Charlson 
Comorbidity 
Index Score 
0  232 (92)  231 (87)  463 (89) 
0.007 
1  19 (8)  25 (9)  44 (9) 
2  1 (0)  9 (3)  10 (2) 
3  0 (0)  2 (1)  2 (0) 
Stage of disease  in situ  69 (27)  18 (7)  87 (17) 
<0.001 
early breast cancer  181 (72)  204 (76)  385 (74) 
locally adv./metastatic  2 (1)  45 (17)  47 (9) 
Tumour Size 
(mm) 
 
<10  63 (36)  19 (9)  82 (41) 
<0.001 
11-20  89 (51)  84 (38))  173 (44) 
20-30  18 (10)  72 (33)  90 (23) 
>30  4 (2)  44 (20)  48 (12) 
LOS (days) 
 
 
Median  1 (0 -13)  4 (0-24)  1 (0-24)  <0.001* 
≤1 day  190 (75)  70 (26)  260 (50) 
<0.001  >1 day  62 (25)  197 (74)  259 (50) 
*Mann-Whitney U test73 
 
 
 
 
 
Table 3.2 The relationship between socio-demographic and clinico-pathologic factors and 
postoperative LOS in Screen Detected Cancers: Univariate Analysis 
 
Factors  Categories 
Subgroup 
total (n) 
Normal LOS 
≤75
th centile (%) 
Prolonged LOS 
>75
th centile (%)  p value 
Age (years)  50 - 69  216  189 (88)  27 (13) 
0.190  >70  36  29 (81)  7 (19) 
Deprivation 
category 
 
Group 1 (Depcat 1/2)  43  36 (84)  7 (16) 
0.621 
Group 2 (Depcat 3/4/5)  149  133 (89)  16 (11) 
Group 3 (Depcat 6/7)  60  49 (82)  11 (18) 
Distance from 
Hospital 
0 - 10 miles  151  128 (85)  23 (15) 
0.334 
11 - 20 miles  64  57 (89)  7 (11) 
21 - 50 miles  34  30 (88)  4 (12) 
>50 miles  3  3 (100)  0 (0) 
Hospital  A  168  143 (85)  25 (15) 
0.652 
B  69  62 (90)  7 (10) 
E  15  13 (87)  2 (13) 
Charlson 
Comorbidity 
 Score 
0  232  203 (88)  29 (13) 
0.170 
1  19  14 (74)  5 (26) 
2  1  1 (100)  0 (0) 
Breast 
Procedure 
BCS  213  189 (89)  24 (11) 
0.147 
Mx  22  15 (68)  7 (32) 
Mx with reconstruction  17  14 (82)  3 (18) 
Axillary 
Procedure 
No procedure*  75  70 (93)  5 (7) 
<0.001 
AS/SNB  162  142 (88)  20 (12) 
AC  15  6 (40)  9 (60) 
Tumour size  ≤10 mm  88  81 (92)  7 (8) 
0.007 
11 – 20 mm  109  94 (86)  15 (14) 
21 – 30 mm  26  20 (77)  6 (23) 
>30 mm  9  6 (67)  3 (33) 
Cancer stage  in situ  69  65 (94)  4 (6) 
0.016 
early breast cancer  181  152 (84)  29 (16) 
locally adv./ metastatic  2  1 (50)  1 (50) 
 
*No axillary procedure group: 58 DCIS, 17 Cancers (3 patients had previous axillary procedures and 14 patients 
underwent axillary procedures at subsequent operations) 
BCS=breast conserving surgery, Mx=mastectomy,  
AS=axillary sampling, AC=axillary clearance, SNB=sentinel node biopsy 
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Table 3.3 The relationship between socio-demographic and clinico-pathological factors and 
postoperative LOS in Symptomatic Cancers: Univariate Analysis 
 
 
Factors  Categories 
Subgroup 
total (n) 
Normal LOS 
≤75
th centile (%) 
Prolonged LOS 
>75
th centile (%)  p value 
Age (years)  <50  68  49 (72)  19 (28) 
0.845 
50 - 69  109  78 (72)  31 (28) 
>70  90  66 (73)  24 (27) 
Deprivation 
category  
Group 1 (Depcat 1/2)  57  44 (77)  13 (23) 
0.008 
Group 2 (Depcat 3/4/5)  108  87 (81)  21 (19) 
Group 3 (Depcat 6/7)  102  62 (61)  40 (39) 
Distance from 
Hospital 
0 - 10 miles  239  171 (72)  68 (29) 
0.605 
11 - 20 miles  13  11 (85)  2 (15) 
21 - 50 miles  6  4 (67)  2 (33) 
>50 miles  9  7 (78)  2 (22) 
Hospital  A  83  58 (70)  25 (30) 
0.725 
B  54  40 (74)  14 (26) 
C  50  39 (78)  11 (22) 
D  46  29 (63)  17 (37) 
E  34  27 (79)  7 (21) 
Charlson 
Comorbidity 
 Score 
0  231  170 (74)  61 (26) 
0.087 
1  25  18 (72)  7 (28) 
2  9  4 (44)  5 (56) 
3  2  1 (50)  1 (50) 
Breast 
Procedure 
BCS  114  69 (61)  45 (40) 
0.026 
Mx  117  95 (81)  22 (19) 
Mx with reconstruction  36  29 (81)  7 (19) 
Axillary 
Procedure 
No procedure*  38  32 (84)  6 (16) 
0.010 
AS/SNB  85  66 (78)  19 (22) 
AC  144  95 (66)  49 (34) 
Tumour size  ≤10 mm  21  16 (76)  5 (24) 
0.930 
11 – 20 mm  90  63 (70)  27 (30) 
21 – 30 mm  73  49 (67)  24 (33) 
>30 mm  45  34 (76)  11 (24) 
Cancer stage  in situ  18  15 (83)  3 (17) 
0.312 
early breast cancer  204  147 (72)  57 (28) 
locally adv./ metastatic  45  31 (69)  14 (31) 
 
* No axillary procedure group: 11 DCIS, 27 Cancers (14 had previous axillary surgery, 7 underwent axillary 
procedures at subsequent operations and 6 had simple mastectomies) 
BCS=breast conserving surgery, Mx=mastectomy,  
AS=axillary sampling, AC=axillary clearance, SNB=sentinel node biopsy 
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Table 3.4 The relationship between socio-demographic and clinico-pathological 
factors and postoperative LOS in Screen Detected and Symptomatic Cancers: 
Multivariate Analysis 
Group  Factor  odds ratio (95% CI)  p value 
Screen detected cancer 
group 
Axillary procedure  5.61 (2.24 – 14.06)  <0.001 
Tumour size  1.61 (0.98 – 2.636)  0.059 
       
Symptomatic cancer group  Axillary procedure  2.06 (1.30 – 3.29)  0.002 
Charlson Comorbidity Score  1.74 (1.00 – 3.06)  0.049 
Depcat  1.48 (1.01 – 2.17)  0.045 
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Table 3.5 Procedures performed, length of postoperative hospital stay and impact on 
cumulative hospital bed days at Hospital A 
 
Procedure  n (%)  Median LOS (Range)  Cumulative hospital bed days (%) 
BCS ± AS/SNB/AC  185 (63)  1 (0-8)  256 (29) 
Mx ± AS/SNB/AC  66 (23)  6 (1-24)  451 (51) 
Re-operations  42 (14)  4 (1-13)  175 (20) 
Total  293  1 (0-24)  882 
 
BCS=breast conserving surgery, Mx=mastectomy,  
AS=axillary sampling, AC=axillary clearance, SNB=sentinel node biopsy 
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Chapter 4 
 
4.0 A pilot randomized controlled trial comparing day surgery with inpatient surgery 
for  breast  cancer  patients  undergoing  breast  conserving  surgery  with  axillary 
sampling or sentinel node biopsy 
4.1 Introduction 
It  was  noted  in  the  last  chapter  that  potentially  about  50  percent  of  women  in 
Glasgow  undergoing  surgery  for  breast  cancer  would  be  suitable  for  day  surgery.  
However, just because they are suitable does not necessarily mean day surgery would be 
the best option for them.  In the systematic review in Chapter 2, day surgery for breast 
cancer  appeared  to  be  safe  and  well  tolerated  with  good  patient  satisfaction  rates.  
However, all the studies in the systematic review were observational studies. In the world 
literature, no randomised controlled trials of day surgery for breast cancer were found.  
None  of  the  studies  had  used  validated  questionnaires  to  measure  either  physical  or 
psycho-social outcomes.  78 
 
 
4.2 Aim 
The aim of this study was to establish in a pilot randomised controlled trial whether 
day  surgery  improved  physical  and  quality  of  life  outcomes  in  breast  cancer  patients 
undergoing  breast  conserving  surgery  with  axillary  sampling  or  sentinel  node  biopsy 
compared with inpatient surgery. 
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4.3 Methods  
The trial was conducted at the breast units of two hospitals in Glasgow.  The study 
received ethical approval from the Local Research Ethics Committee.  Patients with newly 
diagnosed invasive breast cancer undergoing BCS with axillary sampling or SNB, who 
passed the day surgery preassessment criteria (Appendix 4.1), were considered eligible for 
inclusion in the study.  Patients undergoing mastectomy and/or axillary clearance were 
excluded from the study.  Potentially eligible patients had an initial discussion about the 
trial  with  their  consultant  surgeon  and  then  were  handed  a  patient  information  sheet 
(Appendix 4.2) to take home.  They were given a minimum of 24 hours to think about it.  
If agreeable, the patients were consented (Appendix 4.3) for the trial by another visit to the 
hospital.    Randomisation  to  inpatient  surgery  or  day  surgery  was  carried  out  by  the 
researcher using sealed envelopes in blocks of four.  The envelopes were stratified for the 
hospital but not the procedure.  
Patients  randomised  to  inpatient  surgery  were  admitted  to  a  surgical  ward  the 
evening before their operation and discharged home on first postoperative day if well.  
This was the normal practice for all breast cancer patients at these hospitals.   Patients 
randomised to day surgery had their operation at a Day Surgery Unit.  They were admitted 
on the day of their surgery at 1 pm and all being well, discharged home by 6 pm the same 
evening.  
The operations were performed by three of the four surgeons in the two hospitals, 
whether as inpatients or as day surgery.  The anaesthetic management of the patients was 
also similar.  None of the patients received any prophylactic antibiotic cover.  All patients 
had a long acting local anaesthetic agent infiltrated into their wounds at the end of their 
surgery.  Patients discharged from the day surgery unit had a wound check by the district 
nurse the following day.  Protocols for admission to the ward were in place in the event of 
a problem occurring.  Patients in the day surgery group would need admission to hospital 80 
 
 
after surgery, if they had a drain inserted at the time of their operation or if they had 
uncontrolled postoperative nausea and vomiting (PONV).  Any readmission to the hospital 
after discharge due to a postoperative complication was also to be noted.  Patients were 
followed up for a period of 30 days after their surgery. 
The  primary  outcome  measures  were  physical.    Physical  outcomes  assessed 
included surgical site infections (SSIs), other wound related complications, PONV, pain 
and physical activity post surgery.  The secondary outcome was quality of life, which was 
assessed using a FACT B (Functional Assessment of Cancer Therapy Breast) quality of 
life questionnaire.
122 
4.3.1 Surgical Site Infection Form 
Surgical site infections were recorded using a validated SSI form (Appendix 4.4) 
on Day 7 and Day 30 after surgery.
123  They were recorded on the form on Day 7 by visual 
inspection of the wound by the operating surgeon at the postoperative results clinic and on 
Day 30 by telephone conversation with the patient to ask if they had been seen by a general 
practitioner or a district nurse and noted to have an infection and started on antibiotics. 
4.3.2 Patient Diary 
To assess day to day changes in the patient‘s physical activity, pain, and PONV, a 
patient diary (Appendix 4.5) was designed where all these parameters were recorded on 
linear  analogue  scales  for  the  first  seven  days  postoperatively.    A  daily  record  was 
maintained by the patients on scales marked 0 for none to 100 for maximum.  They also 
recorded their daily physical activity and whether they had stepped out of their house.  This 
was used as a marker for physical activity.  The patients also noted daily if they took 
painkillers.  At the end of the week, patient satisfaction with the experience was checked 
by asking them if they would choose the same way of treatment again and whether they 
would recommend day or inpatient surgery to a friend.  Patients were given space in the 
diary to write their own comments and feedback about their experience. 81 
 
 
4.3.3 FACT B Questionnaire  
FACT B questionnaire is a validated breast cancer specific health related quality of 
life questionnaire.
122 The FACT B questionnaire was selected for the study after discussion 
with a Macmillan Consultant in Psychosocial Oncology (Prof. Craig White) who is also a 
member of the SIGN guideline development group for Breast Cancer.
124 The FACT B 
questionnaire (Appendix 4.6) was filled in by the patients firstly after they gave consent for 
the trial and again on Day 7 and Day 30 after surgery to obtain scores at baseline and 2 
time points after surgery for longitudinal comparison.  The FACT B questionnaire consists 
of  a  FACT  G  (General)  component  which  comprises  27  items  and  a  Breast  Cancer 
Subscale with nine items specific to quality of life in breast cancer.
122  FACT G is sub-
divided into four subscales assessing Physical Well-Being (PWB), Emotional Well-Being 
(EWB), Social Well-Being (SWB) and Functional Well-Being (FWB).  The questionnaire 
is for self-administration using a 5-point Likert rating scale from 0 (Not at all) to 4 (Very 
much).  A lower score indicates poorer quality of life.   
Patient  demographics  including  age  and  social  deprivation  categories  (Carstairs 
deprivation index) were recorded.
125 Tumour characteristics were recorded, including type, 
grade, nodal status and Nottingham Prognostic Index (NPI). 
126 
4.3.4 Statistics Analysis 
Before starting the trial, the feasibility of performing BCS with axillary sampling or 
SNB as a day case was assessed by carrying out five cases in the day surgery unit.  The 
five cases performed as day cases went well and the patients had no problems in going 
home  the  same  evening.    The  only  issue  highlighted  was  the  quality  of  postoperative 
instructions given with regards to arm exercises.  The nurses in the day surgery unit were 
then trained regarding the information needed to be given to the patients and patients were 
given written information about arm exercises in the trial.  A survey of 30 inpatients was 
also carried out asking their views about having their operation as a day case, had they 82 
 
 
been offered it.  This showed that 19 of the 30 women interviewed in the wards would 
have been interested in day surgery if it had been offered.  As no previous randomised trial 
had been performed to address day surgery for breast cancer, we were unable to power the 
study.  
Data are presented as median and range.  Where appropriate, differences between 
the inpatient group and the day surgery group data were tested for statistical significance 
using the Mann-Whitney U-test and chi square test or Fisher‘s exact test as appropriate.  
Data from different time periods within each group were tested for statistical significance 
using Wilcoxon signed rank test (SPSS version 15.0, SPSS Inc., Chicago, Illinois). 
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4.4 Results  
The trial was carried out over a 12-month period from March 2007 to March 2008.  
Over the trial period a total of 231 new invasive breast cancers were diagnosed.  Of these, 
92 (40%) patients underwent either mastectomy or axillary clearance or both and hence 
were excluded from the trial.  The remaining 139 (60%) patients underwent BCS with 
axillary sampling or SNB and therefore were potentially eligible for the trial.  From this 
cohort of 139 patients, 50 (36%) were actually assessed for eligibility. (Figure 4.1)  Of 
these, 19 patients were excluded: 11 failed preassessment (5 due to medical problems, 4 
due to high BMI and 2 due to social problems) and 8 were excluded for other reasons.  In 6 
cases, the trial was not discussed with potentially eligible patients due to lack of spaces in 
day surgery for the next few weeks and in 2 cases, the patients were thought to be too 
anxious to cope with a trial by the breast care nurses.  Thirty one patients were included in 
this pilot study.  Of these, 15 and 16 were randomised to the inpatient and the day surgery 
groups  respectively.    One  patient  was  cancelled  due  to  unavailability  of  radiological 
localisation services on the day and one got missed due to an administrative error and 
failed to receive any forms.  One patient in the inpatient group and 2 in the day surgery 
group failed to return their Day 30 FACT B form. 
4.4.1 Baseline characteristics 
The baseline characteristics of the patients at the study entry point are detailed in 
Table 4.1.  Both groups were similar for age, social background and tumour characteristics.  
All patients underwent BCS with either axillary sampling or SNB.  None of the patients 
had any drains inserted at the end of their procedure.  All inpatients were discharged on the 
first postoperative day and all day surgery patients were discharged within four hours of 
their procedure.  None of them had any immediate or delayed postoperative complications 
such as haemorrhage requiring them to go back to theatre or be readmitted to the hospital 
after discharge.  84 
 
 
4.4.2 Physical Outcomes 
Two patients in the inpatient and one in the day surgery group developed surgical 
site infections within the first seven days post operatively.  There were no SSIs between 
Day 7 and Day 30. Other physical outcomes obtained from the Patient Diary show similar 
results for all the parameters in both the groups. (Table 4.2)  Six patients had PONV in the 
first 24 hours after their surgery.  Of these, two patients (one inpatient and one day patient) 
had PONV till the third postoperative day.  Patients‘ pain scores as recorded on a linear 
analogue scale showed significant improvements within the groups during the first week 
but no significant difference was noted between the 2 groups. 
4.4.3 FACT B scores  
The subgroup,  FACT G and FACT B baseline  scores  were similar in  both  the 
groups. (Table 4.3)  
In comparison to baseline scores, there was a significant fall in the FACT B scores 
(indicating poorer quality of life) in the inpatient group by postoperative Day 7. (Table 4.4)  
There was also a significant difference in the FACT G (p = 0.036) and FACT B (p=0.045) 
scores between the inpatient and the day surgery group by Day 7.   
Thirty days after surgery, a repeat scoring of the FACT B questionnaire did not 
show any significant difference for the scores compared to the baseline scores and there 
were no significant differences seen between the two groups. (Table 4.5) 
 
4.4.4 Patient satisfaction 
At the end of the first week, patients were asked, if they would have the operation 
in  the  same  setting  again  and  whether  they  would  recommend  the  same  type  of  care 
(inpatient or day surgery) to a friend.  There was no difference in the two groups with all 
patients staying loyal  to the type of care they received.  There were a few interesting 
comments in the space provided for free-text in the patient diary, interestingly all from 85 
 
 
patients in the day surgery group: ‗I think day surgery suited me because it didn‘t make me 
feel like a ―patient‖, ‗I enjoyed the aftercare in the comfort of my home‘ and ‗discussion 
with breast care nurse was informative and also good to have a face and a name for future 
references‘.  
The present study demonstrates that BCS with axillary sampling or SNB can be 
safely performed in day surgery and that day surgery patients have significantly better 
quality of life by the end of the first postoperative week. 
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4.5 Discussion 
To our knowledge, this study is the first randomised controlled trial comparing day 
surgery and inpatient surgery in breast cancer patients.  The results confirm the findings of 
previous observational studies which have found day surgery for breast cancer to be safe 
and well tolerated with good satisfaction rates, as has been seen in the systematic review 
conducted  by  the  researcher.
127    However,  despite  this,  there  have  been  worries  about 
introducing day surgery for breast cancer patients.  These worries have centred on the 
issues of patient support and psychological adjustment.  Without time in hospital, would 
patients  have  more  difficulties  coping  with  their  cancer  diagnosis?    Or,  would  it  be 
possible to provide the same level of support for women as day cases that they currently 
get as inpatients?  In the USA, for example, the idea of ‗drive through mastectomies‘ has 
been debated in the literature.
128  Locally, while carrying out this study, there were worries 
about  these  issues  from  several  members  of  our  breast  team.    The  present  study  was 
therefore conducted to check the feasibility and acceptability of day surgery in our breast 
cancer population and to obtain a feedback from them.  
Three  patients  (10  percent)  in  this  study,  (two  inpatients  and  one  day  surgery 
patient)  developed  SSIs.    These  patients  were  managed  in  the  community  with  oral 
antibiotics and did not need readmission to the hospital.  This is a higher rate than reported 
for ‗clean surgery‘.  SSIs have been noted to be higher in breast cancer surgery compared 
to  other  clean  surgeries.
129    A  Cochrane  review  and  SIGN  guidelines  suggest  that 
prophylactic antibiotics do reduce the risk of SSIs in patients undergoing surgery for breast 
cancer.
130,131  In our study, none of the patients had prophylactic antibiotics.  Previous 
studies  involving surgical  patients  undergoing  mainly clean procedures have suggested 
lower  incidence  of  SSIs  in  day  surgery  patients  compared  to  inpatients.
132,133    This 
difference could be due to a bias towards relatively fitter patients being operated in day 
surgery.  These patients are also at lower risk of SSIs as they may be undergoing smaller 87 
 
 
procedures.  There may also be ascertainment bias in the published day surgery literature, 
in that, for some general surgical day surgery studies, SSI surveillance was not carried out 
to 30 days and was done using varying methods.  With the small numbers in the present 
study, it is difficult to comment on these issues based on our results.  
PONV and pain were well controlled with medication after discharge and none of 
the patients had a prolonged stay or readmission for these issues.  We noted PONV in 6 of 
the  29  patients.    The  incidence  of  PONV  after  breast  surgery  in  the  early  1990s  was 
reported  to  be  as  high  as  50  percent.
134    With  the  use  of  prophylactic  combination 
antiemetics, this has fallen to between 10 to 20 percent,
135 which is similar to what we see 
in our study.  As all patients in our trial underwent BCS and axillary sampling or SNB, 
pain control was in general very good in both the groups.  Patients seemed to be more 
physically  active  in  the  day  surgery  group  with  more  frequently  stepping  out  of  their 
house, and this was noted to be nearing statistical significance (p=0.085).  It would be of 
interest to note if the trend continues in a larger trial.  
There was significant difference noted in the FACT B scores 7 days postoperatively 
between the two groups. (Table 4.4)  Scores for inpatients dropped more, relative to the 
day surgery group.  A FACT B interpretation paper suggested that the minimum important 
difference between endpoint scores obtained at different time points was 5 to 6 percent.
136   
The median scores for FACT G and FACT B dropped by greater than 10 percent in the 
inpatient  group  compared  to  2  to  3  percent  for  the  day  surgery  group  seven  days 
postoperatively.  Looking at the individual subgroups scores of FACT B, we have noticed 
a  significant  difference  between  our  two  groups  in  the  subgroups  of  PWB  and  EWB. 
(Table 4.4)  The PWB subgroup includes questions about energy levels, nausea, pain and 
feeling ill.  The EWB subgroup includes questions about coping with illness, losing hope, 
feeling sad and worrying about dying.  There was little difference in the FWB and SWB 
subgroups where the questions were more general and about family and social support.  88 
 
 
The questions in the Breast Cancer Subscale were directed more at long term effects of 
surgery and chemo-radiotherapy and there was no difference noted in the groups.  Our day 
surgery patients  therefore seemed to  cope better with  physical  symptoms  after surgery 
itself  and  also  with  their  diagnosis  of  cancer  at  least  in  the  first  week.    It  has  been 
previously suggested that day surgery patients tend to ‗downgrade the seriousness of the 
operation‘ and in doing so have a much better mental attitude towards recovery.
99  The 
above results would support this view.  A repeat evaluation of the FACT B questionnaire 
30 days after surgery shows patients in both the groups to have recovered back to baseline 
levels.  
Patient satisfaction was also measured by asking patients if, given a chance they 
would have the operation again in the same setting and if they would recommend the type 
of care to a friend.  Universally all patients stayed loyal to their type of care.  This suggests 
patient satisfaction with either type of care received to be high.  
Of the 139 potentially eligible patients, 50 (36%) were actually screened for the 
trial.  Eighty nine patients were therefore not assessed for the trial.  A quarter of these 89 
patients were seen by the one local surgeon not taking part in the trial.  Patients in the trial 
had their initial appointment with one of the three other consultants.  Some patients were 
missed when these consultants were oncall, on holiday or too busy to discuss the trial.  
Other  patients  were  probably  missed  because  some  team  members  were  anxious 
themselves about putting patients forward for potential day surgery.  As the year went on, 
everyone  became  more  confident  about  the  idea  as  the  patients  themselves  were 
enthusiastic about day surgery.  In some cases the reason was not recorded for why the 
patient had not been approached. 
Of  the  50  patients  screened,  19  were  excluded.    These  exclusions  may  not  be 
necessary in the future.  Eleven patients failed day surgery preassessment, 2 of these were 
for social problems and 4 due to high BMIs.  By the end of the year, we would not have 89 
 
 
excluded patients for social reasons.  Similarly, the BMI criteria had a cut-off of 35, while 
for other specialties it is 40.  This cut-off criterion could be adjusted.  The 5 patients 
excluded for medical reasons could now have the opportunity to spend the postoperative 
night in a 23-hour bed in our day surgery unit.  90 
 
 
4.6 Conclusions 
In conclusion, although in this pilot study the actual study population is small, day 
surgery for BCS appears to be feasible and highly acceptable amongst patients.  When 
compared  to  inpatients,  day  surgery  patients  appeared  to  have  equivalent  physical 
outcomes and better quality of life outcomes by the end of the first week post surgery.  A 
larger randomised controlled trial may be planned based on the results of this pilot study to 
confirm these results. 
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Table 4.1 Baseline characteristics of Breast Cancer patients in the trial 
   
  Inpatient Group 
n=14 
Day Patient Group 
n=15  p value 
Age (years)  55.5 (45 to 69)  59 (41 to 69)  0.584 
Axillary Sampling/SNB  12/2  14/1  0.473 
Depcat  4 (1 – 7)  5 (1 – 7)  0.453 
Tumour Size (mm)  14 (5 to 27)  12 (7 to 24)  0.264 
Number of nodes removed  4 (1 to 6)  5 (1 to 8)  0.079 
Number of positive  nodes  0 (0)  0 (0 to 1)  0.164 
Estrogen Receptor Status  8 (0 to 8)  8 (0 to 8)  0.251 
Progestorone Receptor Status  8 (0 to 8)  6 (0 to 8)  0.745 
HER2 Receptor Status  All negative  All negative   
NPI (Nottingham Prognostic Index)  3.32 (2.18 to 4.54)  3.20 (2.14 to 5.26)  0.336 
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Table 4.2 Results obtained from the Patient Diary for the first 7 days 
 
  Inpatient Group 
n=14 
Day Patient Group 
n=15  p value 
Wound Infection (n)  2  1  0.181 
PONV (n)  4  2  0.372 
Painkillers taken till (Day)  7 (2 to 7)  5 (2 to 7)  0.372 
Pain Scores D1  40 (15 to 90)  50 (20 to 70)  0.292 
Differential Pain Scores (D4-D1)  -20 (-80 to 10)**  -10 (-40 to 20)*  0.833 
Differential Pain Scores (D7-D1)  -20 (-80 to 20)*  -30 (-70 to 25)**  0.624 
First stepped out of house  (Day)  3 (1 to 7)  2 (1 to 6)  0.358 
No. of days out in 1
st week (days)  3 (1 to 6)  4 (2 to 7)  0.085 
*p<0.05, **p<0.01 
Day = Postoperative day  
D4-D1 = Difference of Postoperative scores (Day 4 – Day 1) 
D7-D1 = Difference of Postoperative scores (Day 7 – Day 1)     
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Table 4.3 Baseline FACT B scores for the inpatient and the day patient groups 
                                                                                                                                                                    
  Inpatient Group 
n=14 
Day Patient Group 
n=15  p value 
Physical Well Being  27 (23 to 28)  26 (20 to 28)  0.382 
Social Well Being  26 (17 to 28)  25.7 (18.7 to 28)  0.739 
Emotional Well Being  19.1 (11 to 24)  18 (2 to 24)  0.630 
Functional Well Being  24 (18 to 27)  26 (20 to 28)  0.913 
Breast Cancer Subscale  30.2 (22.5 to 34)  26 (15 to 35)  0.042 
FACT G  96.4 (73 to105)  90 (69.6 to 108)  0.458 
FACT B  126.2 (104.5 to 138)  118 (89.1 to 143)  0.106 
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Table 4.4 Changes in FACT B scores, 7 days post surgery 
 
Differential Scores  
 (Day 7 – Day 1) 
Inpatient Group 
n=14 
Day Patient Group 
n=15  p value 
Physical Well Being  -4.0 (-20.0 to -1.0)**  -2.0 (-5.0 to 3.0)*  0.029 
Social Well Being  0.0 (-9.3 to 11.0)  -1.0 (-10.5 to 8.4)  0.963 
Emotional Well Being  -2.4 (-5.0 to 12.0)  2.0 (-4.4 to 6.0)  0.039 
Functional Well Being  -3.0 (-18.0 to 5.0)**  -2.0 (-16.0 to 6.0)*  0.380 
Breast Cancer Subscale  -2.0 (-5.0 to 3.0)*  0.0 (-14.9 to 7.0)  0.142 
FACT G  -12.0 (-41.0 to 11.0)**  -3.0 (-20.4 to 11.0)  0.036 
FACT B  -15.4 (-44.0 to 10.0)**  -2.9 (-35.3 to 12.0)  0.045 
*p < 0.05, ** p < 0.01 when compared with baseline values within the same group 
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Table 4.5 Changes in FACT B scores, 30 days post surgery 
 
Differential Scores         
 (Day 30 – Day 1) 
Inpatient Group 
n=13 
Day Patient Group 
n=13  p value 
Physical Well Being  -1.0 (-5.0 to 1.5)*  -2.0 (-7.0 to 4.0)  1.000 
Social Well Being  0.0 (-5.8 to 2.0)  0.0 (-6.3 to 2.0)  0.801 
Emotional Well Being  1.0 (-3.0 to 7.0)  2.8 (-4.0 to 6.0)  0.579 
Functional Well Being  0.0 (-8.0 to 5.0)  0.0 (-13.3 to 6.0)  0.650 
Breast Cancer Subscale  -1.0(-6.0 to 6.0)  1.0 (-15.0 to 7.0)  0.341 
FACT G  -2.5 (-13.3 to 9.0)  2.0 (-25.6 to 10.0)  0.505 
FACT B  -2.5 (-16.3 to 10.7)  5.9 (-40.6 to 13.0)  0.397 
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Figure 4.1: Details of all invasive breast cancers diagnosed during trial period. 
 
 
 
231 invasive cancers during trial 
period 
92  excluded  as  they  underwent 
mastectomy +/- axillary clearance 
139 eligible patients 
50 patients assessed for the trial 
31 patients included in trial 
19 patients excluded 
1.  11 failed preassessment 
2.  6 patients, no day case slots available 
3.  2 patients too anxious to discuss trial 
 
 
89 patients not assessed for trial 
1.  30 patients seen by one surgeon not 
taking part in trial 
2.  28  missed due to other commitments 
of the surgeons 
3.  No reason recorded in 31 patients 97 
 
 
5.0 Overall Conclusions 
In  this  thesis,  the  feasibility,  acceptability  and  safety  of  day  surgery  for  breast 
cancer surgery have been investigated.  At the outset, it was considered that day surgery 
for breast cancer was potentially a feasible option in the breast cancer patients in Glasgow.  
The evidence for this in literature was examined and the present practise in Glasgow was 
recorded  and  analysed  to  ascertain  whether  day  surgery  was  feasible.    A  randomised 
controlled trial was then conducted to address the acceptability and safety of performing 
breast cancer surgery as day cases.  
Day surgery may be a feasible alternative for breast cancer patients in Glasgow 
with nearly 50 percent of patients being potentially suitable for it.  
The postoperative length of stay for breast cancer patients appeared to be mainly 
influenced by type of axillary procedure they undergo. 
Postoperative  length  of  stay  did  not  appear  to  be  affected  by  their  age,  which 
hospital they were operated at and the distance between the patient‘s residence and the 
hospital. 
The planning for inpatient beds for breast cancer patients should take into account 
the proportion of symptomatic cancers being treated and the reoperations being performed.  
There  is  evidence  from  literature  and  the  pilot  randomised  controlled  trial 
performed  that  compared  to  inpatients,  day  surgery  patients  have  equivalent  physical 
outcomes and better quality of life outcomes after their surgery. 98 
 
 
6.0 Further Research  
The suitability of patients who were discharged within a day of their surgery for 
true day surgery needs to be assessed further.  It is not clear how many of these patients 
would be able to go home within four hours of their operation and how many would need 
to stay in overnight.  Present preassessment criteria only pass patients if they are fit for true 
day surgery.  Further criteria need to be developed for 23-hour care.  Factors which may 
influence a patient‘s decision to stay overnight include their home circumstances such as 
whether they would be looked after by a responsible adult and their willingness to go home 
with a drain in situ.  In the randomised controlled trial, only two out of the 50 patients 
failed preassessment for social reasons. 
Another area which needs further research is the role of day surgery in the older 
patient.  The breast cancer population is an aging population and one argument put forward 
is that day surgery may not be for the older patients.  However, it has been noted in a study 
that postoperative cognitive dysfunction in elderly patients is less in day surgery patients 
compared  to  inpatients.
137    This  is  an  area  which  can  be  researched  in  a  randomised 
controlled trial with cognitive function measure as one of the outcomes. 
Over the time that this research was conducted, two new day hospitals have been 
built in Glasgow.  One in the North and the other in the South of Glasgow and the first 
patients were operated in June 2009. Day surgery for breast cancer has been carried out in 
both  hospitals  in  a small selected  group of patients  and this  has  gone well.   There  is 
probably no possibility now to continue a randomised trial of day surgery as we are being 
encouraged to develop day surgery.  However, we should continue to audit our practise in 
the day surgery setting looking at various outcomes. 99 
 
 
6.1 Tools for Audit 
Based on the results of this thesis and an in-depth study of the literature, I would like to 
propose that the following few measures may be developed into an audit tool to assess the 
quality of a day surgery service for breast cancer. Validated questionnaires should be used 
where possible. 
1.  Type of surgery and mode of presentation: 
i)  Proportion of patients having BCS 
ii)  Proportion of BCS patients having day surgery (with details of screen detected and 
symptomatic cancers) 
2.  Information and support provided 
i)  Meetings with Breast Care Nurse. When and where. 
ii)  Information provided to patients 
iii)  Education tools used, if any. 
3.  Preassessment and Discharge criteria 
i)  Preassessment criteria for 23-hour care if any 
ii)  Any early discharge protocol for inpatients 
iii)  Can patients go home with drain in situ? If yes, then who do they contact in case of 
a problem? 
iv)  Physiotherapy advice given 
4.  Morbidity, readmission due to morbidity and mortality rates 
5.  Reoperation rates 
6.  Number of trips to hospital, both before and after surgery 
7.  Return to daily activity as measured using a patient diary and postoperative functional level 
at Day 7 
8.  Patient satisfaction surveys 
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Appendices 
Appendix 2.1 Search Strategy for Systematic Review 
 
Databases Searched a.m. Friday 19
th September 2008: 
 
Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) 1950 to September 
Week 4 2008 
British Nursing Index 1985 to September 2008 
Cumulative Index to Nursing & Allied Health Literature (CINAHL) 1982 to September Week 3 2008 
EMBASE 1980 to 2008 Week 38 
PsycINFO 1967 to September Week 3 2008 
The Cochrane Library 
 
Search strategy summary 
 
Keywords: 
(breast cancer$ or breast neoplasm$ or breast tumor$ or breast tumour$ or  Breast  Adenocarcinoma$ or 
Breast Carcinoma$ or Breast Sarcoma$ or Cystosarcoma Phylloides or Intraductal Carcinoma$ or Phyllodes 
Tumor or Paget Nipple Disease or breast surgery or breast conser$ or axillary surgery or breast cancer 
axillary surgery or breast conservation surgery or breast biops$ or lymph node excision$ or sentinel lymph 
node biops$ or lymphadenectom$ or lymph node dissection$ or Breast Lesion$) or  
or axillary surgery or axillary sampling or  (conservative surgery and breast)) 
 
(day surgery or day case$ or ambulatory surgery or out patient$) 
 
(double blind or meta analysis or randomi?ed or systematic review$ or random allocation) 
 
Subject Headings: 
 
exp mastectomy/ 
exp breast cancer/ 
exp breast neoplasms/ 
breast biopsy/ 
lymph node excision/ or sentinel lymph node biopsy/ 
exp breast surgery/ and exp cancer surgery/ 
lymphadenectomy/ or lymph node dissection/ 
―Breast Lesion"/ 
axillary lymph node/ or sentinel lymph node/ 
and 
Ambulatory Surgical Procedures/ 
Ambulatory Surgery/ 
 
 
Medline and Embase Subject Headings that do not explode: 
 
Ambulatory Surgical procedures 
Ambulatory Surgery 117 
 
 
Breast Biopsy 
Lymph Node Dissection 
Breast Lesion 
Breast Biopsy 
 
Limits: 
Human/Humans 
Publication types:  
controlled clinical trial or guideline or meta analysis or practice guideline or randomized controlled trial 
[Publication type limit is not valid in: British Nursing Index,CINAHL,EMBASE, PsycINFO; records were 
retained] 
 
Exclusions: 
Animal$ or monkey$ 
 
The following were excluded to eliminate false drops identified by the extended keyword search: 
Skin Neoplasms/ 
Melanoma/ 
Urogenital Surgical Procedures/ 
Urogenital Neoplasms/ 
 
 
Search strategy: 
 
1. exp mastectomy/ 
2. exp breast cancer/ 
3. exp breast neoplasms/ 
4. breast biopsy/ 
5. lymph node excision/ or sentinel lymph node biopsy/ 
6. exp breast surgery/ and exp cancer surgery/ 
7. lymphadenectomy/ or lymph node dissection/ 
8. "Breast Lesion"/ 
9. axillary lymph node/ or sentinel lymph node/ 
10. (breast cancer$ or breast neoplasm$ or breast tumor$ or breast tumour$ or breast adenocarcinoma$ or 
beast carcinoma$ or breast sarcoma$ or cystosarcoma pylloides or intraductal carcinoma$ or phyllodes tumor 
or  paget  nipple  disease  or breast  surgery  or  breast  conser$  or  axillary  surgery  or  breast  cancer  axillary 
surgery or breast conservation surgery or breast biops$ or lymph node excision$ or sentinel lymph node 
biops$ or lymphadenectom$ or lymph node dissection$ or breast Lesion$).mp. [mp=ti, ab, hw, tc, id, it, ot, 
nm, sh, tn, dm, mf] 
11. (conservative surgery and breast).mp. [mp=ti, ab, hw, tc, id, it, ot, nm, sh, tn, dm, mf] 
12. (axillary surgery or axillary sampling).mp. [mp=ti, ab, hw, tc, id, it, ot, nm, sh, tn, dm, mf] 
13. (day surgery or day case$ or ambulatory surgery or out patient$).mp. [mp=ti, ab, hw, tc, id, it, ot, nm, sh, 
tn, dm, mf] 
14. "Ambulatory Surgical Procedures"/ 
15. "Ambulatory Surgery"/ 
16. or/1-12 
17. or/13-15 
18. 16 and 17 
19. limit 18 to human 
20. "Urogenital Surgical Procedures"/ 
21. "Melanoma"/ 
22. "Skin Neoplasms"/ 
23. "Urogenital Neoplasms"/ 
24. 19 not (or/20-23) 118 
 
 
25. limit 24 to (controlled clinical trial or guideline or meta analysis or practice guideline or randomized 
controlled trial) 
26. (double blind or meta analysis or randomi?ed or systematic review$ or random allocation).mp. [mp=ti, 
ab, hw, tc, id, it, ot, nm, sh, tn, dm, mf] 
27. 24 and 26 
28. 25 or 27 
29. 24 not 28 
30. remove duplicates from 28 
31. remove duplicates from 29 
32. 30 or 31 
33. remove duplicates from 32 
 
Cochrane Library search strategy 
 
#1 (breast cancer* or breast tumor* or breast tumour* or breast surgery or breast conserv* or axillary surgery 
or breast conservation):ti,ab,kw 
 
#2 (day surgery or day case* or ambulatory surg*):ti,ab,kw 
 
#3 (#1 and #2) 
 
#4 (double blind or randomised or randomized or meta analysis or meta-analysis):ti,ab,kw 
 
#5 (#3 and #4) 
 
#6 MeSH descriptor Ambulatory Surgical Procedures explode all trees 
 
#7 (#5 and #6) 
 
Cochrane Systematic Reviews were not relevant. 
 
From #3 references to 1 Technology Assessment and 4 Economic Evaluations were saved. 
 
Clinical Trials were not relevant in #3, even when keywords for study types were added in #5, hence MeSH 
heading added to contextualise in #7.  All 16 references were on anaesthetics. 119 
 
 
Appendix 4.1 Preassessment Criteria 
Patients failed day surgery preassessment if: 
  BMI > 35 
  Patient unable to arrange a responsible adult escort 
  Patient unable to arrange a responsible adult carer at home for the first 24 hours 
  Patient unhappy to be a day patient 
  MI within last 1 year 
  BP systolic > 170 mmHg, diastolic > 110 mmHg 
  Breathlessness on lying flat or waking at night "gasping for breath" 
  Asthma,  wheeze  or  breathlessness:  Shortness  of  breath  on  walking;  Currently 
taking oral steroids or has done so within last 3 months; Admitted to hospital with 
an exacerbation of asthma within last 3 months 
  Seizures within last 6 months 
  Suffered from stroke or mini stroke (TIA) within last year 
  Suffers from a diagnosed bleeding problem 
  Severe renal disease with deranged urea and electrolytes 
  Anaesthetic problems: Patient or relative suffers from malignant hyperthermia 
  IV drug abusers if currently injecting 
  Patients drinking on an average 10 units or more of alcohol per day  
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Appendix 4.2 Patient Information Sheet  
     
 
Clinical trial comparing day care and in-patient care for breast cancer 
 
What does this mean?  
This  is  a  trial  comparing  day  care  with  in-patient  care  to  find  out  which  method  of 
treatment is of most benefit to patients with breast cancer.  
 
You are being invited to take part in a research study. Before you decide it is important for 
you to understand why the research is being done and what it will involve. Please take time 
to read the following information carefully and discuss it with others if you wish. Ask us if 
there is anything that is not clear or if you would like more information. Take time to 
decide whether or not you wish to take part. 
   
What is the purpose of the study? 
Over the past 10 years, breast cancer treatments have changed and often less surgery is 
needed. In your case we only need to remove a part of your breast and will also need to 
take 4 glands from under the arm.   
At the moment patients having your operation are admitted the day before surgery and 
discharged either in the evening after their surgery or the next day. For many years our 
patients with pre-cancer have had their surgery as day patients with no problems. The 
operation to the breast that these women have is exactly the same as your operation. The 
only difference being that you also need glands removed from under your arm.  
 
The aim of the study is to find out which method of treatment is better for our patients. We 
would be comparing things like - wound infection rates, patient anxiety and satisfaction 
levels and recovery after the surgery. 
Each patient would be followed up for a period of a month after their operation.  
1 Why have I been chosen? 
All patients who are to undergo breast-conserving surgery with axillary sampling at the 
Victoria Infirmary would be possible candidates for the study. Patients who fall into this 
group would undergo an assessment at the Day Surgery Unit at the Victoria Infirmary. 
Only those people who are found to be fit for day surgery would be asked to join the trial.  
 
2 Do I have to take part? 
It is up to you to decide whether or not take part. If you decide to take part you would be 
given this information sheet to keep and be asked to sign a consent form. If you decide to 
take part  you are still free to withdraw at any time and without giving any reason.  A 
decision to withdraw at any time, or a decision not to take part, will not affect the standard 
of care you receive. 
 
 
3 What will happen to me if I take part? 
Sometimes  because we  do not  know  which way  of treating is  best,  we need to  make 
comparisons. People are put into groups and compared. 
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If you consent for the trial, one of the doctors would open a sealed envelope, which would 
say whether the operation should be carried with in-patient care or day care. The chance of 
being part of one or the other group is 50-50. What happens after that depends on which 
group you are in and is shown in the chart on the next page. 
 
4 What do I have to do? 
For the study it is very important that you fill in the diary provided to you everyday for 10 
days and bring it with you when you come to the results clinic after your operation. You 
will be asked to complete a separate questionnaire. This should take no more than 10 
minutes of your time.  
You would also be given a further questionnaire to be filled 30 days after your operation. 
This would have to be posted back to us in a stamped, addressed envelope provided to you. 
 
5 What are the possible disadvantages and risks of taking part? 
No disadvantages are anticipated when taking part in the study, as you would undergo the 
same operation in both circumstances. It is important to know which method is better for 
you and hopefully the study would give us that answer.   
 
6 What are the possible benefits? 
Studies in other countries have shown day surgery to be beneficial for the patient. We are 
trying to find out what is best for patients in our community. 
 
7 What if something goes wrong? 
There  is  a  small  chance  that  patients  in  the  day  care  group  may  require  overnight 
admission to a ward in the hospital if they are not ready to go home for any reason.  
 
8 Will my taking part in this trial be kept confidential? 
All information that is collected about you during the course of the research will be kept 
strictly confidential. Any information about you that leaves the hospital will have your 
name and address removed so that you cannot be recognised from it. 
Your GP would be notified about your participation in the trial. 
 
9 What will happen to the results of the research study? 
The results of the study would help in the planning of treatment for future patients. The 
results would be presented at national and international meetings and would be published 
in medical journals. You will not be identified in any report or presentation. 
 
10 Who is funding this study? 
There is no extra funding required for this study.  
 
11 Who has reviewed the study? 
The Research Ethics Committee 
The Breast Team at the Victoria Infirmary 
Outline of what happens after you are allocated to a group. 
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The important thing to remember is that the surgery being performed in both the groups 
would be the same. The difference would be in the type of care i.e. in-patient care or day 
care. All precautions would be taken to make sure that the best care is provided.  
 
Emergency contact numbers- Surgical SHO: 0141 2016000 Page: 5021 
For further information about trial-  
 
Mr. Sekhar Marla (Research Fellow): 0141 2115440       
 
We would like to thank you for taking part in this study. 
In-patient care group  Day care group 
Admitted to Ward-B one day before surgery. 
X-ray localisation a day before or on the morning 
of surgery. 
Seen by breast care nurse in the ward. 
Undergo  surgery  and  discharged  the  following 
day if well. 
 
Admitted to Day Surgery Unit on the morning 
of surgery. 
X-ray localisation on the morning of surgery. 
Seen by breast care nurse in the DSU. 
Undergo  surgery  in  the  afternoon  and 
discharged the same day if well. 
Patient  to  fill  in  a  daily  diary  that 
would be  provided and to bring  it 
back  to  the  results  clinic  the 
following week. 
District  nurse  visits  the  patient  the 
following morning. 
Patient to fill in a daily diary that would 
be provided and  to  bring it back to the 
results clinic the following week. 
 
 
 
 
Patient  seen  back  in  results 
clinic 7-10 days after surgery. 
Patient  seen  back  in  results 
clinic 7-10 days after surgery. 
 
30 days after surgery patient to fill 
in a further questionnaire and post 
it in a stamped addressed 
envelope that would be provided. 
30 days after surgery patient to fill in 
a further questionnaire and post it in 
a stamped addressed envelope that 
would be provided. 123 
 
 
Appendix 4.3 Consent Form for Trial 
 
 
 
 
Project Title: A pilot randomised clinical trial of day surgery for breast cancer 
 
Patient name:    Date of Birth:   
 
To be completed by the patient 
 
  Please Initial 
  Yes  No 
 
Have you read the Participant Information Sheet (Version1.1/ Dated 08/02/07)?     
 
Have you had the opportunity to ask questions and to discuss the study?     
 
Have you received satisfactory answers to all of your questions?     
 
Have you received enough information about the study?     
 
Do you agree to let your GP be informed about your participation in the trial?     
 
 
 
Do you understand that you are free to withdraw from the study: 
 
Please Initial 
  Yes  No 
 
At any time?     
 
Without having to give a reason?     
 
Without affecting your future medical care?     
 
Do you agree to take part in this study?     
 
 
 
 
Signed 
   
Date 
 
 
Name in block letters 
     
 
Signature of witness 
   
Date 
 
 
Name in block letters 
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Appendix 4.5 Patient Diary 
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Daily questions from Day 1 to Day 7 
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Final Questions 
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